2012IncidencijaIMortalitetOdRaka1 PDF

Institut za javno zdravlje Srbije Dr Milan Jovanovi Batut
Institute of Public Health of Serbia Dr Milan Jovanovi Batut

Odeljenje za prevenciju i kontrolu nezaraznih bolesti
Department for Prevention and Control of Noncommunicable Diseases
INCIDENCIJA I MORTALITET OD RAKA

U CENTRALNOJ SRBIJI
CANCER INCIDENCE AND MORTALITY
IN CENTRAL SERBIA
2012
REGISTAR ZA RAK U CENTRALNOJ SRBIJI

CANCER REGISTRY OF CENTRAL SERBIA
ISBN 86-7358-030-7
IZVETAJ BR. 14
REPORT No. 14
Beograd, 2014.

INCIDENCIJA I MORTALITET OD RAKA

U CENTRALNOJ SRBIJI
CANCER INCIDENCE AND MORTALITY
IN CENTRAL SERBIA
2012
REGISTAR ZA RAK U CENTRALNOJ SRBIJI

CANCER REGISTRY OF CENTRAL SERBIA
ISBN 86-7358-030-7
IZVETAJ BR. 14
REPORT No. 14
Beograd, 2014.
Izdava
Published by
Direktor
Director
Prim. dr sc. med. Dragan Ili / Dragan Ilic, MD, PhD

Mr sc. dr Dragan Milju / Dragan Miljus, MD, M. Sc. - Head of Department
Dr Sneana ivkovi/ Snezana Zivkovic, MD
Dr Sneana Plavi / Snezana Plavsic, MD
Mr sc. med. Nataa Mickovski Katalina / Natasa Mickovski Katalina, MD, M.Sc.
Dr Ivana Rakoevi / Ivana Rakocevic, MD
Dr Jelena Jankovi/ Jelena Jankovic MD
Zorica Boi, vii dijetetski nutricionista / Zorica Bozic, senior dietitian nutritionist
Ureivaki odbor
Editorial Board
Mr sc. dr Dragan Milju / Dragan Miljus, MD, M. Sc.
Dr Sneana ivkovi / Snezana Zivkovic, MD
Dizajn i priprema za tampu

Design and typesetting
Informatika podrka / IT support

CanReg 4 Descriptive Epidemiology, Internacional Agenci for Research on Cancer,WHO
Lektor
Language editor
Mr sc. Tamara Gruden / Mr Tamara Gruden
Korespondencija
Correspondence to
Institut za javno zdravlje Srbije

Dr Subotia 5, 11 000 Beograd, Srbija
Tel: +381 (011) 2684 566/160, 115
Fax: +381 (011) 2684 140
E-mail: [email protected]
Web site://www. batut.org.rs
RECENZIJE
Registar za rak centralne Srbije predstavlja najznaajniji izvor podataka o obolevanju i

umiranju od malignih bolesti u naoj zemlji. Dizajniran po tipu populacionog registra, prua
relevantne informacije o incidenciji i mortalitetu od raka u Srbiji i njihovim trendovima. Ovi
parametri su od krucijalnog znaaja ne samo za praenje epidemioloke situacije kada su u
pitanju maligne bolesti, ve i za evaluaciju razliitih mera i programa koji se sprovode u cilju
njihove prevencije i smanjenja bremena ovih bolesti u naoj populaciji, kao to je npr.
implementacija skrininga za odreene maligne bolesti.
Imajui u vidu obiman set podataka koji se odnose na prirodu bolesti, kao i respektabilne
parametre kvaliteta ovih podataka, Registar za rak u naoj zemlji predstavlja izuzetno znaajan
resusrs za praktini rad lekara, edukaciju i istraivanja. Podaci ovog Registra slue lekarima
razliitih specijalnosti da proire svoja znanja o malignim bolestima, faktorima rizika za njihov
nastanak i faktorima prognoze, u cilju to ranijeg otkrivanja i izbora najoptimalnijeg naina
leenja.
Podaci Registra za rak centralne Srbije se takoe koriste u svim vidovima nastave
epidemiologije, onkologije i drugih oblasti koje se tiu malignih bolesti, na medicinskim
fakultetima u zemlji, poev od osnovnih studija, preko specijalistikih i subspecijalistikih, do
doktorskih studija. Zahvaljujui tome, znaajno je porasla upotrebna vrednost podataka Registra
koji sve vie postaje i ozbiljan resurs za razliite vrste epidemiolokih i drugih istraivanja, to je
dokumentovano u velikom broju raznovrsnih publikacija, ukljuujui i doktorske teze.
Beograd, 30.10.2013. godine
Institut za epidemiologiju,
Medicinski fakultet Univerzitet u Beogradu
Prof. dr Tatjana Pekmezovi

RECENZIJE
Populacioni registar za rak je najstariji registar u Srbiji i ima neprocenjiv znaaj za

sagledavanje optereenosti drutva malignim bolestima, planiranje strategije za prevenciju i
kontrolu raka, praenje uspenosti skrininga i drugih preventivnih programa, planiranje i
organizaciju zdravstvene zatite, kao i za izvoenje epidemiolokih i klinikih istraivanja. Od
1998. godine Registar za rak je primljen u Internacionalnu (IACR) i Evropsku asocijaciju
registara za rak (ENCR), to je doprinelo afirmaciji Srbije kao zemlje koja ide u korak sa
visokorazvijenim zemljama.
Poseban akcenat treba staviti na kvalitet Registra, koji je rezultat decentralizovanog

naina prikupljanja podataka (na nivou okruga), aktivnog i pasivnog nadzora, korienja vie
izvora informacija o obolelima i umrlima od raka, adekvatne informatike podrke, unapreenja
znanja zdravstvenih radnika i primene metodologije meunarodnih asocijacija (IARC i ENCR).
Autori su na originalan i sistematizovan nain prikazali podatke o obolevanju i umiranju od raka.

Retko se sree da se suvoparni statistiki podaci prezentuju na ovako zanimljiv, izuzetno jasan
i prijemiv nain, inei ovu publikaciju korisnom ne samo strunjacima preventivnih grana
medicine, nego i kliniarima i nemedicinarima. Osim toga, uspeno je pronaena mera ukupnog
obima informacija sa preciznim formulacijama prihvatljivim za iroku javnost.
Ukupno uzevi ova publikacija zasluuje pohvale ne samo sa aspekta kvaliteta

prezentovanog materijala, ve, moda ak i vie, sa aspekta utemeljivanja neophodnosti
kontinuiranog praenja kretanja obolevanja i umiranja od malignih bolesti.
Neophodno je da Ministarstvo zdravlja Republike Srbije prepozna znaaj ovog

populacionog registra i da podri sve aktivnosti koje mogu da doprinesu daljem njegovom
unapreenju, to bi uticalo na poboljanje zdravstvene politike i menadmenta, a samim tim i na
smanjenje broja obolelih i umrlih od raka, produenje ivotnog veka obolelih, poboljanje
kvaliteta njihovog ivota i do redukcije ili eliminacije potencijalnih faktora rizika.
Beograd, 30.10.2013. Institut za epidemiologiju,
Prof. dr Sandra ipeti-Grujii

RECENZIJE
Registar za rak u centralnoj Srbiji autorske grupe Odeljenja za prevenciju i kontrolu
nezaraznih bolesti Instituta za javno zdravlje Srbije Dr Milan Jovanovi Batut u Beogradu kroz
precizne i dobro sistematizovane tabelarne i grafike prikaze daje epidemioloke parametre
malignih neplazmi na teritoriji centralne Srbije.
Od brojnih afirmativnih utisaka, izdvajaju se dva osnovna.
Prvo, jasno prikazana statistika morbiditeta i mortaliteta od malignih bolesti, prihvatljiva za

razliite specijalnosti medicine izvan domena epidemiologije, ukazuje na visoko struni i
posveeni rad grupe autora, na osnovu koga svi poslenici u onkologiji dobijaju vrstu taku
oslonca za svoja dalja istraivanja u sloenoj oblasti malignih bolesti.
Drugo, populacioni registar daje nacionalne koordinate za orijentisanje u oblasti

onkologije upravo u periodu kada se u organizaciji Ministarstva zdravlja Republike Srbije
razvijaju programi organizovane prevencije raka dojke, debelog creva i grlia materice u Srbiji i
promoviu nacionalni vodii dobre klinike prakse dijagnostike i leenja malignih bolesti
navedenih lokalizacija, to obeava dobar sinergizam u razvoju onkologije zasnovane na
dokazima i standardima.
Registar za rak e stoga sigurno biti esto citiran izvor u klinikim studijama u onkologiji, a
autorima moe da se poeli da od aktuelnog registra bude bolje samo njegovo naredno izdanje.
Beograd, 28.11.2013. godine
Institut za onkologiju i radiologiju Srbije,
Prof. dr Zorica Miloevi

REVIEWS
Cancer Registry of Central Serbia is the most important source of morbidity and mortality
data for malignant diseases in our country. Designed as a population based registry, it provides
relevant information considering incidence and mortality rates from cancer in Serbia and their
trends. These parameters are crucial not only for monitoring on epidemiological situation
regarding malignant diseases, but also for the evaluation of various preventive measures and
programs implemented with the aim to prevent and reduce the burden of these diseases in our
population, such as screening programs for specific malignant diseases.
Bearing in mind the extensive set of data regarding the nature of the disease, as well as
respectable parameters of quality of these data, Cancer Registry in our country is extremely
significant resource for medical practise, education and research. Data from the Registry are
serving physicians of different specialties to broaden their knowledge about malignant diseases,
their risk and prognostic factors, with the aim of early detection and optimal treatment choice.
Cancer Registry of Central Serbia data are also used in all aspects of education in
epidemiology, oncology and other areas related to malignant diseases on medical universities in
the country, ranging from undergraduate through specialist and subspecialist to doctoral studies.
As a result, utility value of the registry has significantly increased and become a serious
resource for different types of epidemiological and other studies, as documented in a large
variety of publications, including a doctoral thesis.
Belgrade, 30.10.2013
Institute of Epidemiology,
University of Belgrade Faculty of Medicine
Prof. dr Tatjana Pekmezovic

REVIEWS
Population based Cancer Registry is the oldest registry in Serbia and is invaluable for
understanding the burden of malignant diseases, planning strategies for the prevention and
control of cancer, monitoring the effectiveness of screening and other preventive programs,
planning and organization of health care and epidemiological and clinical studies. Since 1998
Cancer Registry was accepted into the International (IACR) and the European Association of
Cancer Registries (ENCR), which contributed to the promotion of Serbia as a country that keeps
up with the developed countries.
Special emphasis should be placed on the quality of the Registry, which is the result of
decentralized data collection (at the district level), active and passive surveillance, the use of
multiple sources of information about patients and deaths from cancer, adequate IT support,
improving the knowledge of health professionals and applied methodology of international
associations (IARC and ENCR). Authors in genuine and systematic way display data about
incidence and mortality of cancer. It is rarely seen that "less interesting" statistics is presented in
such an interesting, extremely clear and responsive manner, making this publication useful not
only for experts of preventive medicine, but also for clinicians and other non-medical experts. In
addition, they successfully found a measure of the total volume of information with precise
definitions acceptable to the general public.
Altogether, this publication deserves praise not only from the viewpoint of the material
presented, but perhaps even more, in terms of the necessity of laying foundations for continuous
monitoring of trends of incidence and mortality from cancer.
It is essential for the Serbian Ministry of Health to recognize the importance of the
population based Registry and to support all activities which may contribute to its further
improvement, could lead to the improvement of health policy and management, and thereby
reduce the number of patients and deaths from cancer, prolongation of life in patients, improving
their quality of life and the reduction or elimination of potential risk factors.
Institute of Epidemiology,
Prof. dr Sandra Sipetic-Grujicic

REVIEWS
Cancer registry of central Serbia by the authors from Department for Prevention and
Control of NCD of Institute of Public Health of Serbia Dr Milan Jovanovic Batut gives the
epidemiological parameters of malignant neoplasms in the territory of central Serbia, which are
shown by precise and well systematized tables and graphics. Of the numerous affirmative
impressions, it is worth mentioning two of them.
First, the statistics of morbidity and mortality from malignant diseases is clearly shown, by
comprehensive and acceptable way not only for epidemiologists but also for other different
medical specialties. This is the result of a highly professional and dedicated work of the authors
on the basis of which all employees in oncology can get a solid point of support for their further
research in the complex field of malignant diseases.
Secondly, population cancer registry provides national coordinates for orientation in the
field of oncology, which is especially important during the ongoing implementation of the projects
organized by the Ministry of Health of the Republic of Serbia: the national screening programs of
breast, colon and cervix cancer and the national guidelines for good clinical practice for
diagnostics and treatment of three cancer localization listed above, which promises good
synergism in the development of oncology based on evidence and standards.
Cancer Registry will certainly be frequently cited source in many articles in the field of
clinical oncology, with best wishes to the authors that the only issue better than the current
registry will be its next edition.
Institute for Oncology and Radiology of Serbia,
Prof. dr Zorica Milosevic

SADRAJ / CONTENTS
Uvod i objanjenja
Introduction and Comments
Tabele i slike / Tables and Figures
1. Broj stanovnika prema uzrastu i polu, centralna Srbija, 2012. godina

Population of Central Serbia by age and sex, 2012
2. Broj stanovnika prema okruzima i polu, centralna Srbiji, 2012. godina

Population of Central Serbia by administrative regions by sex, 2012
3. Stanovnitvo prema uzrastu i polu, centralna Srbija, popis 2002. i 2012.

godine
Population of Central Serbia by age sex, census 2002 and estimate 2012
4. Broj novoobolelih osoba od raka prema polu, centralna Srbija, 19902012.

Number of new cancer cases by sex, Central Serbia, 1990 - 2012
5. Broj umrlih osoba od raka prema polu, centralna Srbija, 19902012.

Number of death cancer cases by sex, Central Serbia, 1990 - 2012
6. Standardizovana incidencija i mortalitet od raka na 100.000 stanovnika,

centralna Srbija, 19902012. godina
Standardized cancer incidence and mortality rates per 100.000 population,
Central Serbia, 1990 2012
7. Standardizovane stope mortaliteta od vodeih lokalizacija raka na 100.000

stanovnika, mukarci, centralna Srbija, 19902012 godina
Standardized cancer mortality rates per 100.000 population, males,
Central Serbia, 1990 - 2012
8. Standardizovane stope mortaliteta od vodeih lokalizacija raka na 100.000

stanovnika, ene, centralna Srbija, 19902012 godina
Standardized cancer mortality rates per 100.000 population, females, Central
Serbia, 1990 -2012
9. Vodee lokalizacije u obolevanju od raka prema polu, centralna Srbija, 2012. godina
The leading cancer sites by sex, Central Serbia, 2012
10. Vodee lokalizacije u umiranju od raka prema polu, centralna Srbija, 2012. godina
Deaths for leading cancer sites by sex, Central Serbia, 2012
11. Broj novoobolelih sluajeva od raka prema vodeim lokalizacijama,

okruzima i polu, centralna Srbija, 2012. godina
Number of new cancer cases by sex and leading primary sites, Central Serbia, 2012
12. Sirove stope incidencije od raka prema vodeim lokalizacijama, okruzima

i polu, centralna Srbija, 2012. godina
Crude cancer incidence rates by sex and leading primary sites, Central Serbia, 2012
13. Standardizovane stope incidencije od raka prema vodeim lokalizacijama
Standardized cancer incidence rates by sex and leading primary sites,
Central Serbia, 2012
14. Broj umrlih sluajeva od raka prema prema vodeim lokalizacijama,

Number of death cancer cases by sex and leading primary sites,
15. Sirove stope mortaliteta od raka prema vodeim lokalizacijama,

Crude cancer mortality rates by sex and leading primary sites,
16. Standardizovane stope mortaliteta od raka prema vodeim lokalizacijama,

Standardized cancer mortality rates by sex and leading primary sites,
17. Ukupan broj novoobolelih i broj novoobolelih od raka sa procentom

registrovanih samo na osnovu prijave smrti,
prema primarnoj lokalizaciji i polu, centralna Srbija, 2012. godina
Total number of new cancer cases and number and percentage of cases registered
from death certificates only, of corpus uteri, Central Serbia, 2012
18. Broj novoobolelih sluajeva od raka, prema primarnoj lokalizaciji,

uzrastu i polu, centralna Srbija, 2012. godina
Number of new cancer cases by primary site, age and sex,
19. Sirove i standardizovane stope incidencije od raka na 100 000 stanovnika,

prema primarnoj lokalizaciji, uzrastu i polu, centralna Srbija, 2012. godina
Crude and standardized cancer incidence rates per 100 000 population
by primary site, age and sex, Central Serbia, 2012
20. Broj umrlih sluajeva od raka, prema primarnoj lokalizaciji,

Number of death cancer cases by primary site, age and sex,
21. Sirove i standardizovane stope mortaliteta od raka na 100.000 stanovnika,

prema primarnoj lokalizaciji, uzrastu i polu, centralna Srbija, 2012. godina
Crude and standardized cancer mortality rates per 100 000 population
by primary site, age and sex, Central Serbia, 2012
22. Ukupan broj novoobolelih, broj i procenat histoloki i citoloki verifikovanih

sluajeva raka prema primarnoj lokalizaciji i polu, centralna Srbija, 2012. godina
Total number of new cancer cases, number and percentage of histologically and
cytologically confirmed cancer cases, by primary site and sex, Central Serbia, 2012
23. Broj novoobolelih i incidencija od raka prema primarnoj lokalizaciji,
Number of new cancer cases and cancer incidence rates by primary site,
age and sex, Central Serbia, 2012
24. Broj umrlih i mortalitet od raka prema primarnoj lokalizaciji,

Number of death cancer cases and cancer mortality rates by primary site,
UVOD
Populacioni registar za rak osnovan je u Srbiji 1970. godine na osnovu Plana statistikih
istraivanja od interesa za Republiku (Sl. glasnik SRS br. 32/69).
U cilju primene jedinstvene metodologije u voenju Registra u svim teritorijalnim
jedinicama bive Jugoslavije, 1986. godine doneti su Uputstvo o nainu i postupku prijavljivanja
lica obolelih od malignih neoplazmi (Sl. list SFRJ, br. 3/86) i Pravilnik o obrascu Registra i nainu
njegovog voenja, obrascu prijave i postupku prijavljivanja i odjavljivanja odreenih bolesti (Sl.
glasnik SRS, br. 42/86).
Neprecizno uputstvo, nedovoljna edukacija zdravstvenih radnika, kao i nedostatak
informatike podrke imali su za posledicu subregistraciju novootkrivenih sluajeva raka, kao i
relativno lo kvalitet podataka na samoj prijavi. U periodu od 1986. do 1995. godine, broj
obolelih sluajeva malignih tumora koji su prijavljeni Registru bio je priblino isti ili ak i manji od
broja umrlih od raka.
Polazei od zakonske obaveze i uloge Registra (pre svega, za procenu optereenosti
drutva rakom, donoenje programa primarne prevencije, planiranje onkoloke zdravstvene
zatite, kao i za klinika i epidemioloka istraivanja), u toku 1996. godine pristupljeno je
njegovoj reorganizaciji u skladu sa preporukama Internacionalne (Interational Agency for
Research on Cancer - IACR) i Evropske (European Network of Cancer Registries ENCR)
asocijacije registara za rak.
Reorganizacija je obuhvatala:
decentralizaciju (registri se vode na nivou okruga, a baza podataka za centralnu Srbiju
se nalazi u Institutu za javno zdravlje Srbije),
pored pasivnog i aktivni nain prikupljanja podataka,
nove izvore informacija,
edukaciju zdravstvenih radnika,
informatiku podrku i
povratni sistem informacija.
Zahvaljujui uspenoj reorganizaciji, u toku 1998. godine Registar za rak u centralnoj
Srbiji je primljen u Internacionalnu (IACR) i Evropsku asocijaciju registara za rak (ENCR).
Posle navedenih aktivnosti i vremenskog perioda od nekoliko godina, koji je neophodan
za stabilnost podataka, ostvareni su uslovi za izradu prvog izvetaja u decembru 2002. godine.
U registrima koji funkcioniu vie decenija, zbog mnogobrojnih izvora podataka i potrebe
za njihovom proverom i analizom, uobiajeni vremenski period za prikupljanje podataka iznosi
dve godine nakon ega se publikuje izvetaj.
INTRODUCTION
The Population Register for Cancer was formed in Serbia in 1970, originated from the
Plan of Statistical Research of Interest for the Republic (Official Gazette of the Republic of
Serbia No. 32/69).
In 1986, aiming to apply a unified Register implementation methodology in all territorial
units of Former Yugoslavia, the Guidelines On Ways And Procedures Of Reporting Persons
With Malign Neoplasms (Official Gazette SFRY, No. 3/86) and the Regulation Book For The
Register Form And The Method Of Updating, The Report Forms And Reporting And Cancelation
Procedures For Certain Diseases (Official Gazette Gazette of the Republic of Serbia No. 42/86)
were adopted.
Unprecise Guidelines, insufficient education of the medical personnel, as well as the lack
of informatics support resulted in the subregistration of newly found cases of cancer, as well as a
relatively poor quality of data on the report forms themselves. In the period of 1986 - 1995, the
number of cases with malignant tumors reported to the Register was approximately the same or
even lower compared to the number of cases deceased from cancer.
Starting from legal obligations and role of the Register, (foremost for the evaluation of the
cancer burden on society, adoption of primary prevention programs, planning oncology health
care, as well as clinical and epidemiological research), the reorganization of the Register began
in 1996, in accordance with the recommendations of the Interational Agency for Research on
Cancer - IACR, and European Network of Cancer Registries - ENCR.
The reorganization encompassed:
- Decentralization (registers are formed on the level of regions, while the main database
for Central Serbia is located in the Institute of Public Health of Serbia),
- Apart from passive, active data collection,
- New sources of information,
- Education of medical personnel,
- Informatics support and
- Feedback system of information.
During 1998, due to a successful reorganization, the Cancer Register in Central Serbia
was admitted into the Interational Agency for Research on Cancer (IACR) and European
Network of Cancer Registries (ENCR).
Following the afore-mentioned activities and several years period necessary for achieving
stability of the data, conditions were created for issuing the first Report in December 2002.
In Registers functioning over a period of several decades, due to numerous data sources
and the need to check and analyze them, the usual time span for data collection is two years,
after which the Report is published.
METOD
Registar za rak u centralnoj Srbiji obuhvata podatke o: linim karakteristikama

obolelih/umrlih, moguoj pojavi multiplog primarnog tumora, datumu utvrivanja sadanjeg
oboljenja, nainu dijagnostike, karakteristikama tumora (primarna i sekundarna anatomska
lokalizacija, histoloki tip, stadijum), ishodu bolesti, kao i podatke o zdravstvenoj ustanovi
koja je prijavila maligni tumor.
Izvori informacija o obolelim/umrlim od raka su podaci iz instituta za onkologiju,
onkolokih dispanzera, onkolokih klinika, bolnikih i vanbolnikih zdravstvenih ustanova,
patohistolokih/citolokih, hematolokih i drugih laboratorija, prijava smrti, fondova
zdravstvenog osiguranja i ciljanih istraivanja.
Informatiku podrku Registru pruio je programski paket CanReg4 (Department of
Descriptive Epidemiology, IARC, Lyon, France, 2002).
U cilju obezbeenja kvalitetnog prikupljanja, unosa, uvanja, obrade i analize
podataka u Registru, primenjena je metodologija meunarodnih asocijacija (IARC i ENCR)
registara za rak.
Za analizu umiranja od malignih tumora u centralnoj Srbiji u 2011. godini, korieni
su nepublikovani podaci Republikog zavoda za statistiku. Izvor podataka o populaciji bio je
popis stanovnitva 2011. godine Republikog zavoda za statistiku.
Maligni tumori su ifrirani prema Meunarodnoj klasifikaciji bolesti deseta revizija,
knjiga 1- (ifre C00-C96) i prema Meunarodnoj klasifikaciji onkolokih bolesti tree
izdanje (ifre 8000/3-9941/3) - International Classification of Diseases for Oncology Third
Edition, World Health Organization, 2000, Geneva. Registrom nisu obuhvaeni tumori in
situ (ifre D00-D09).
U izvetaju pored nestandardizovanih, prikazane su i standardizovane stope
incidencije (tabele 6, 13, 19, 23) i mortaliteta (tabele 7, 16, 21, 24). Navedene stope
standardizovane su metodom direktne standardizacije, a kao standardna populacija
koriena je populacija sveta (ASR-W), Evrope (ASR-E) i trankova (ASR-TRUNC).
Uee prijavljenih sluajeva malignih tumora koji su registrovani samo na osnovu
prijave smrti prikazano je na tabeli 17.
METHOD
The Central Serbia Cancer Register includes the following data: personal
characteristics of new cases/deceased, possible appearance of multiple primary tumors,
date of determination of current illness, diagnostic methods, tumor characteristics (primary
and secondary anatomy localization, histology type, stage), outcome of the disease, as well
as data on the health institution reporting the malign tumor.
Information sources concerning new cancer cases/deceased cases are data from the
oncology institutes, oncology dispensaries, oncology clinics, hospitals and out-patients
health institutions, pahtohistology/cytology, hematology and other laboratories, death
reports, health insurance funds and targeted research.
The Register is informatically supported by the CanReg4 progame package
(Department of Descriptive Epidemiology, IARC, Lyon, France, 2002).
With the aim of providing quality in collection, entry, keeping, processing and analysis
of data in the Register, the methodology of international associations was applied (IARC I
ENCR) for cancer registers.
Unpublished data of the Republic Statistics Institute were used for the analysis of
death due to malign tumors in Central Serbia in 2011.
The source of data concerning the population is 2011 Census, Statistical Office of the
Republic of Serbia.
Malign tumors are coded according to the International Classification of Diseases -
Tenth Revision, Volume 1(codes C00-C96) and according to the International Classification
of Diseases for Oncology - Third Edition (codes 8000/3-9941/3), World Health Organization,
2000, Geneva. The Register does not include tumors in situ (codes D00-D09).
Apart from crude rates, the Report includes standardized incidence rates (tables 6,
13, 19, 23) and mortality rates (tables 7, 16, 21, 24). These rates were standardized by the
method of direct standardization, with the World (ASR-W), European (ASR-E) or truncated
(ASR-TRUNC) population as the standard population.
The percentage of new malign tumor cases registered only on the basis of death
reports (table 17).
DEFINICIJE
Incidencija je broj novodijagnostikovanih sluajeva raka u definisanoj populaciji,

prijavljenih registru u datoj kalendarskoj godini.
Uzrasno specifina stopa incidencije je broj novoobolelih od raka u definisanoj
uzrasnoj grupi (najee petogodinji interval) na 100.000 stanovnika te uzrasne grupe.
Mortalitet je broj sluajeva umrlih od raka koji se javljaju u definisanoj populaciji
tokom odreenog vremenskog perioda.
Uzrasno specifina stopa mortaliteta je broj umrlih od raka u definisanoj uzrasnoj
grupi (najee petogodinji interval) na 100.000 stanovnika te uzrasne grupe.
Standardizovane stope incidencije i mortaliteta predstavljaju fiktivne vrednosti koje se
dobijaju odreenim tehnikim postupkom, uvoenjem standardne populacije, obino je to:
populacija sveta (ASR-W), Evrope (ASR-E) ili tranka (ASR-TRUNC). Njima se prevazilaze
razlike (najee po polu i uzrastu) koje postoje u razliitim populacijama, tako da su
pogodne za poreenja.
DEFINITIONS
Incidence is the number of newly diagnosed cancer cases in a defined population,

reported to the Register in the given calendar year.
The age-specific incidence rate is the number of new cancer cases in a defined age-
group (usually five-year interval) per 100 000 population of that age group.
Mortality is the number of cases deceased from cancer appearing in a defined
population during a determined period of time.
The age-specific mortality rate is the number of deceased from cancer in a defined
age-group (usually five-year interval) per 100 000 population of that age group.
Standardized incidence and mortality rates represent fictive values reached by a
certain technique, introducing standard population: usually World (ASR-W), European
(ASR-E) or truncated population (ASR-TRUNC). They are used to eliminate differences
(mostly gender and age) existing in different populations and are, therefore, convenient for
comparison.
U realizaciji ovog izvetaja uestvovali su zdravstveni radnici i saradnici:
Instituta za javno zdravlje u Niu i Kragujevcu

Zavoda za javno zdravlje na teritoriji centralne Srbije
Hospitalnog Registra za rak Instituta za onkologiju i radiologiju Srbije
Instituta klinikog centra Srbije i klinikog centra u Niu
Kliniko bolnikih centara u Beogradu i Kragujevcu
Instituta za zdravstvenu zatitu majke i deteta Dr Vukan upi''
Univerzitetske deije klinike u Beogradu
Ginekoloko akuerske klinike Narodni front''
Zdravstvenih centara
Specijalnih / optih bolnica, i
Domova zdravlja na teritoriji centralne Srbije.
Health experts and administrative staff from the following institutions participated in
the realization of this Report:
- Institutes of Public Health of Nis and Kragujevac;

- Institutes of Public Health on the territory of Central Serbia;
- Hospital Cancer Register of the Oncology and Radiology Institute of Serbia;
- Institutes of the Clinical Centre of Serbia and the Clinical Centre of Nis;
- Clinical-Hospital Centres in Belgrade and Kragujevac;
- Institute for Health Care of Mother and Child ''Dr Vukan upi'';
- University Childrens' Clinic in Belgrade;
- Gyneacology and Obstretics Clinic ''Narodni front'';
- Health Centres;
- Special / General Hospitals and
- Primary Health Centres on the territory of Central Serbia.
Koordinatori okrunih Registara za rak / Coordinators of Cancer Registries:
Zavod za javno zdravlje abac / Institute of Public Health Sabac

Dr Olivera Stojanovi, specijalista socijalne medicine / Olivera Stojanovic, MD, specialist
specialist in social medicine
Vesna Maksimovi, vii sanitarni tehniar / Vesna Maksimovic, senior sanitary technician
Zavod za javno zdravlje Valjevo / Institute of Public Health Valjevo

Marija Jovanovi, medicinska sestra / Marija Jovanovic, nurse
Zavod za javno zdravlje Poarevac / Institute of Public Health Pozarevac

Dr Goran Nikoli, specijalista epidemiologije / Goran Nikolic, MD, specialist in epidemiology
Sran Klimek, vii sanitarni tehniar / Srdjan Klimek, senior sanitary technician
Institut za javno zdravlje Kragujevac / Institute of Public Health Kragujevac

Asist. dr Gordana orevi, specijalista epidemiologije / Ass. Prof. Gordana Djordjevic, MD,
PhD, specialist in epidemiology
Jelena Hadi - Radisavljevi, vii sanitarni tehniar / Jelena Hadic - Radisavljevic, senior
sanitary technician
Zavod za javno zdravlje uprija / Institute of Public Health Cuprija

Dr Vesna Stefanovi, specijalista epidemiolog / Vesna Stefanovic, MD, specialist in
epidemiology
Sonja Anelkovi, vii sanitarni tehniar / Sonja Anelkovic, senior sanitary technician
Zavod za javno zdravlje Zajear / Institute of Public Health Zajecar

Dr Svetlana ivkovi, specijalista epidemiolog / Svetlana Zivkovic, MD, specialist in
epidemiology
Nena orevi, operater / Nena orevic, IT technician
Zavod za javno zdravlje Uice / Institute of Public Health Uzice

Dr sc. med. Biljana Mijovi / Biljana Mijovi MD, PhD, specialist in epidemiology
Dr Aleksandra Andri, specijalista epidemiolog / Aleksandra Andric, MD, specialist in
epidemiology
Marija Dulovi, sanitarni tehniar / Marija Dulovic, sanitary technician
Zavod za javno zdravlje aak / Institute of Public Health Cacak

Dr Aksentije Toi, specijalista epidemiolog / Aksentije Tosic, MD, specialist in epidemiology
Radoica Gojgi, dipl. inenjer metalurgije / Radoica Gojgic, dipl. engineer of metallurgy
Zavod za javno zdravlje Kraljevo / Institute of Public Health Kraljevo

Dr Vladan aponji, specijalista epidemiolog / Vladan Saponjic, MD, specialist in
epidemiology
Dr Verica uki, specijalista epidemiolog / Verica Djukic, MD, specialist in epidemiology
Zvonko Marinkovi, vii sanitarni tehniar / Zvonko Marinkovic, senior sanitary technician
Zavod za javno zdravlje Kruevac / Institute of Public Health Krusevac

Dr Mirjana Avramovi, specijalista epidemiolog / Mirjana Avramovic, MD, specialist in
epidemiology
Verica Mijailovi, vii sanitarni tehniar / Verica Mijailovic, senior sanitary technician
Insitut za javno zdravlje Ni / Institute of Public Health Nis

Prim.Dr Mirko Ili, specijalista epidemiolog / Mirko Ilic, MD, specialist in epidemiology
Danijela Milenkovi Stankovi, sanitarni tehniar/ Danijela Milenkovic Stankovic, sanitary
technician
Zavod za javno zdravlje Pirot / Institute of Public Health Pirot

Dr Radmila Zec, specijalista epidemiolog / Radmila Zec, MD, specialist in epidemiology
Danijela Kosti, vii sanitarni tehniar/ Danijela Kostic senior sanitary technician
Zavod za javno zdravlje Leskovac / Institute of Public Health Leskovac

Dr Zorana Kuli, specijalista epidemiolog/ Zorana Kulic MD, specialist in epidemiology
Violeta Kosti, sanitarni tehniar / Violeta kostic, sanitary technician
Zavod za javno zdravlje Vranje / Institute of Public Health Vranje

Dr Svetlana Stojanovi, specijalista socijalne medicine / Svetlana Stojadinovic, MD,
specialist in social medicine
Petar Velikovi, zdravstveni statistiar / Petar Velickovic, health statistician
Gradski zavod za javno zdravlje Beograd / Institute of Public Health Beograd

Mr sc. med. Ljubinka Mareti, specijalista socijalne medicine / Ljubinka Marcetic, MD, M.
Sc. specialist in social medicine
Dr Svetlana Trtica, specijalista socijalne medicine / Svetlana Trtica, MD, specialist in social
medicine
Aleksandra uki, zdravstveni statistiar / Aleksandra Cukic, health statistician
Tabela 1. Broj stanovnika prema uzrastu i polu, centralna Srbija, 2012*. godina
Table 1. Population of Central Serbia by age and sex, 2012*
Uzrast Mu{ karci @ene Ukupno

Age Males Females Total
0-4 124845 118083 242928
5-9 132305 125356 257661
10-14 131737 125132 256869
15-19 150057 141986 292043
20-24 162758 155835 318593
25-29 177296 172005 349301
30-34 182293 178529 360822
35-39 183848 183256 367104
40-44 172490 174552 347042
45-49 170265 175591 345856
50-54 182498 191395 373893
55-59 206885 220112 426997
60-64 189546 210189 399735
65-69 118999 139188 258187
70-74 112989 142827 255816
75+ 171545 252668 424213
Ukupno (Total) 2570356 2706704 5277060
Tabela 2. Broj stanovnika prema okruzima i polu, centralna Srbija, 2012*. godina
Table 2. Population of Central Serbia by administrative districts by sex, 2012*
Teritorija Mu{ karci @ene Ukupno

District Males Females Total
Grad Beograd 787410 876808 1664218
Kolubarski 85787 87321 173108
Ma~vanski 146921 149535 296456
Ra{ ki 153047 155670 308717
Moravi~ki 103578 107464 211042
Zlatiborski 140575 143641 284216
Rasinski 118030 121836 239866
[ umadijski 143124 148911 292035
Pomoravski 103241 109567 212808
Brani~evski 88286 93380 181666
Podunavski 97595 100368 197963
Zaje~arski 57763 60638 118401
Borski 60417 63199 123616
Ni{ avski 183961 190410 374371
P~injski 101907 100421 202328
Jablani~ki 106864 107320 214184
Topli~ki 45632 45075 90707
Pirotski 46218 45140 91358
Centralna Srbija
2570356 2706704 5277060
(Central Serbia)
Slika 1. Stanovni{ tvo prema uzrastu i polu, centralna Srbija, 2011 i 2012*. godina
Figure 1. Population of Central Serbia by age and sex, 2011 and 2012*
uzrast
2011 (ages) 2012
2002 75 +
70 do 74
65 do 69
60 do 64
55 do 59
50 do 54
45 do 49
40 do 44
35 do 39
30 do 34
25 do 29
20 do 24
15 do 19
10 do 14
5 do 9
0 do 4
300 200 100 0 100 200 300 300 200 100 0 100 200 300
u h I lj a d a m a - Popis, 2011 - Republiki zavod statistiku, Beograd, 2012

(thousands) - Census,2011 - Republic statistical office,Belgrade,2012
* - Procena,2012 - Republiki zavod za statistiku,Beograd 2013
Mukarci
300 (males)
200 100 0 (females)
ene 100 200 * -300
Estimate,2012 -Republic statistical office,Belgrade,2013
u h i lj a d a m a
(t h o u s a n d s )
Tabela 3. Broj novoobolelih osoba od raka prema polu, centralna Srbija, 19902012. godina
Table 3. Number of new cancer cases by sex, Central Serbia, 1990 - 2012
G o d i n e (Y e a r s )
P o l (Sex ) 1990* 1991* 1992* 1993* 1994* 1995* 1996* 1997* 1998* 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Mukarci (Males ) 4879 4479 4417 2900 2639 3101 8987 9412 9788 9964 11270 12110 12449 12350 12801 12679 12835 13475 13261 14012 13625 14130 13860
ene (Females ) 5019 4696 4174 3354 3250 3955 8236 8562 9053 9661 10853 11249 11449 11594 11954 11690 11758 12187 11974 12651 12531 12819 12358
Ukupno (Total ) 9898 9175 8591 6254 5889 7056 17223 17974 18841 19625 22123 23359 23898 23944 24755 24369 24593 25662 25235 26663 26156 26949 26218
* subregistracija (subregistration)
Tabela 4. Broj umrlih osoba od raka prema polu, centralna Srbija, 19902012. godina
Table 4. Number of death cancer cases by sex, Central Serbia, 1990 - 2012
G o d i n e (Y e a r s )
P o l (Sex ) 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Mukarci (Males ) 5612 5658 6083 6093 6146 6287 6488 6736 6874 6962 7206 7149 7496 7655 7728 7858 7968 8290 8338 8506 8605 8592 8694
ene (Females ) 4202 4303 4544 4581 4569 4907 4919 5052 5288 5350 5447 5553 5571 5832 5980 6142 6146 6083 6317 6536 6448 6332 6537
Ukupno (Total ) 9814 9961 10627 10674 10715 11194 11407 11788 12162 12312 12653 12702 13067 13487 13708 14000 14114 14373 14655 15042 15053 14924 15231
Slika 2. Standardizovana incidencija i mortalitet od raka na 100.000 stanovnika, centralna Srbija, 19902012. godina
Figure 2. Standardized cancer incidence and mortality rates per 100.000 population, Central Serbia, 1990 - 2012
350.0
Incidencija
(Incidence)
300.0
250.0
Mortalitet (Mortality)
200.0
150.0
100.0 Mukarci (Males)
50.0
ene (Females)
0.0
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
G o d i n e (y e a r s)
Slika 3. Standardizovane stope mortaliteta od vodeih lokalizacija raka na 100.000 stanovnika, mukarci, centralna Srbija, 19902012.godine
Figure 3. Standardized cancer mortality rates per 100.000 population, males, Central Serbia, 1990 - 2012
60
Standardizovane stope raka na 100.000
Standardized cancer rate per 100.000
50 C34 - Plua/bronh
(Lung/bronchus)
40
C18-C20 - Kolon/rektum
(Colon/rectum)
30
C16 - eludac (Stomach)
20
C61 - Prostata (Prostate)

10
C25 - Pankreas (Pancreas)

0
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
G o d in e ( Y e a r s )
Slika 4. Standardizovane stope mortaliteta od vodeih lokalizacija raka na 100.000 stanovnika, ene, centralna Srbija, 19902012.godine
Figure 4. Standardized cancer mortality rates per 100.000 population, females, Central Serbia, 1990 - 2012
25
C50 - Dojka (Breast)
Standardizovane stope raka na 100.000
Standardized cancer rate per 100.000
20
C34 - Plua/bronh
(Lung/bronchus)
15
C18-C20 - Kolon/rektum
(Colon/rectum)
10
C53 - Grli materice
(Cervix uteri)
5
C16 - eludac
(Stomach)
0
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
G o d in e ( Y e a r s )
Slika 5. Vodee lokalizacije u obolevanju od malignih tumora kod mukaraca, centralna Srbija, 2012. godina
Figure 5. The leading cancer sites in males, Central Serbia, 2012
Bubreg
Usna upljina i farinks
(C64)
(C00-C10)
Kidney
Pankreas Mouth and pharynx
2.1%
(C25) Mozak 2.4%
Pancreas (C71)
Jetra
2.3% Brain
(C22)
Larinks 2.3%
Liver
(C32)
1.7%
Larynx Druge lokalizacije
3.3% Other sites
29.1%
eludac
(C16)
Stomach
3.7%
Mokrana beika
(C67)
Bladder
5.6%
Plua /bronh
Prostata
(C34)
(C61) Kolon / rektum Lung / bronchus
Prostate (C18-C20) 22.5%
12.6% Colon / rectum
12.4%
Slika 6. Vodee lokalizacije u obolevanju od malignih tumora kod ena, centralna Srbija, 2012. godina
Figure 6. The leading cancer sites in females, Central Serbia, 2012
Mokrana beika
(C67) Mozak Jetra
Pankreas Bladder, (C71) (C22)
(C25) 2.1% Brain , Liver,
Pancreas, 2.1% 1.5%
2.2%
eludac
(C16)
Stomach Druge lokalizacije
2.1% Other sites,
30.5%
Ovarijum
(C56)
Ovary,
3.7%
Materica
(C54)
Corpus uteri,
5.8%
Plua i bronh
(C34)
Lung and bronchus,
7.8%
Dojka
(C50)
Breast ,
Grli materice 25.8%
Kolon i rektum
(C53)
(C18-C20)
Cervix uteri
Colon and rectum,
8.0%
8.5%
Slika 7. Vodee lokalizacije u umiranju od malignih tumora kod mukaraca, centralna Srbija, 2012. godina
Figure 7. The leading cancer sites, deaths, males in Central Serbia, 2012
Mozak
Jetra Larinks (C71)
(C22) (C32) Brain
Liver Larinx 3.1% Leukemije
3.3% 3.2% (C91-C95) Leukaemias
2.7%
Mokrana beika (C67)

Bubreg
Bladder
(C64)
4.8%
Kidney
1.9%
Pankreas
(C25) Druge lokalizacije
Pancreas Other sites
5.1% 18.7%
eludac
(C16)
Stomach
5.7%
Plua / bronh (C34)
Lung & bronchus
Prostata 29.8%
(C61)
Prostate Kolon / rektum
8,7% (C18-C20)
Colon & rectum
13.0%
Slika 8. Vodee lokalizacije u umiranju od malignih tumora kod ena, centralna Srbija, 2012. godina
Figure 8. The leading cancer sites, deaths, females in Central Serbia, 2012
Mozak
(C71)
Brain
Jetra 3.4%
(C22) Materica, telo
Liver (C54)
Ovarijum 3.6% Corpus uteri
(C56) 2.7% Leukemije
Ovary (C91-C95)
4.5% Leukaemias
2.6%
eludac
(C16)
Stomach
4.8%
Druge lokalizacije Other sites

23.6%
Grli materice (C53)
Cervix uteri
5.1%
Dojka
(C50)
Breast
18.0%
Pankreas
(C25)
Pancreas
Plua/bronh (C34)
5.9% Kolon/ rektum (C18-C20) Lung & bronchus
Colon & rectum 14.7%
11.2%
Tabela 5. Broj novoobolelih sluajeva od raka prema vodeim lokalizacijama i okruzima, mukarci,
Table 5. Number of new cancer cases by leading primary sites, males, regions in Central Serbia, 2012
O k r u g (R e g i o n )
centralna Srbija
Grad Beograd
Primarne lokalizacije (10-MKB)
Pomoravski
Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Primary sites (ICD-10)
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Plua i bronh, (C34) 3117 1243 116 174 106 128 163 132 147 95 82 129 65 44 207 83 100 50 53
Lung and bronchus
Prostata (C61) 1748 688 34 77 75 71 54 96 109 44 43 49 44 45 136 32 91 27 33
Prostate
Kolon i rektum (C18-C20) 1721 541 75 93 89 77 72 115 99 60 52 48 48 34 141 43 49 20 65
Colon and rectum
Mokrana beika (C67) 775 196 27 45 44 44 24 44 55 31 19 28 15 29 85 16 41 15 17
Bladder
eludac (C16) 517 99 24 38 31 34 33 28 36 17 14 15 9 10 40 23 40 11 15
Stomach
Larinks (C32) 458 140 4 33 28 17 20 18 33 14 16 23 11 7 41 17 13 10 13
Larynx
Usna uplj. i farinks (C00-C10) 326 119 8 32 14 10 20 13 15 11 5 7 8 9 18 7 18 6 6
Mouth and pharynx
Pankreas (C25) 322 49 11 30 27 11 27 13 29 5 14 17 19 13 22 3 12 6 14
Pancreas
Mozak (C71) 314 72 16 14 20 10 19 19 29 5 12 17 7 7 21 15 17 3 11
Brain
Bubreg (C64) 293 69 14 25 18 16 17 12 24 10 9 13 5 11 23 5 11 3 8
Kidney
Jetra (C22) 233 22 10 24 18 13 8 2 11 6 16 19 7 16 22 8 11 5 15
Liver
Leukemije (C91-C95) 207 42 8 17 14 16 10 4 25 6 0 1 12 8 22 8 5 2 7
Leukaemias
Druge lokalizacije 3829 1358 168 175 184 139 181 196 286 178 95 135 85 84 226 74 117 49 99
Other sites
Sve lokalizacije (C00-C97) 13860 4638 515 777 668 586 648 692 898 482 377 501 335 317 1004 334 525 207 356
All sites
Sve lokalizacije bez koe (C44) 12238 4055 446 692 587 499 552 580 801 380 352 446 313 273 954 310 479 194 325
All sites but skin (C44)
Tabela 6. Broj novoobolelih sluajeva od raka prema vodeim lokalizacijama i okruzima, ene,
Table 6. Number of new cancer cases by leading primary sites, females, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd

Pomoravski
Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski

Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Dojka (C50) 3186 1353 109 123 110 124 135 202 181 97 71 84 57 62 232 70 83 39 54
Breast
Kolon i rektum (C18-C20) 1053 311 48 58 43 42 45 71 64 27 39 28 40 23 105 25 40 7 37
Colon and rectum
Grli materice (C53) 986 384 25 20 32 44 47 39 61 29 31 32 26 29 77 51 29 14 16
Cervix uteri
Plua i bronh (C34) 959 350 47 54 34 43 42 33 76 24 34 51 22 18 55 16 36 12 12
Lung and bronchus
Materica (C54) 722 276 17 21 39 23 12 40 33 20 28 29 18 18 61 21 43 6 17
Corpus uteri
Ovarijum (C56) 453 107 24 20 19 18 23 25 27 9 18 15 9 31 45 11 25 12 15
Ovary
Pankreas (C25) 272 50 18 12 11 10 20 10 31 4 9 8 9 6 26 7 15 15 11
Pancreas
Mokrana beika (C67) 262 82 4 16 13 13 10 20 17 12 11 14 7 8 22 3 4 3 3
Bladder
Mozak (C71) 261 70 13 4 13 10 24 15 21 6 9 9 6 5 20 5 16 8 7
Brain
eludac (C16) 255 46 12 15 10 17 15 15 18 7 12 8 5 14 16 10 23 6 6
Stomach
Jetra (C22) 185 15 6 19 20 10 9 13 6 2 7 10 3 8 29 3 7 4 14
Liver
Leukemije (C91-C95) 158 39 11 9 6 14 11 2 17 6 0 0 5 2 15 1 7 8 5
Leukaemias
Druge lokalizacije 3606 1314 137 183 165 127 161 225 311 149 92 103 74 94 193 59 95 47 77
Other sites
All sites
Tabela 7. Stope incidencije od raka na 100.000 stanovnika prema vodeim lokalizacijama i okruzima, mukarci,
Table 7. Cancer incidence rates per 100.000 population by leading primary sites, males, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd
Pomoravski
Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Plua i bronh, (C34) 121.3 157.9 135.2 118.4 69.3 123.6 116.0 111.8 102.7 92.0 92.9 132.2 112.5 72.8 112.5 81.4 93.6 109.6 114.7
Lung and bronchus
Prostata (C61) 68.0 87.4 39.6 52.4 49.0 68.5 38.4 81.3 76.2 42.6 48.7 50.2 76.2 74.5 73.9 31.4 85.2 59.2 71.4
Prostate
Kolon i rektum (C18-C20) 67.0 68.7 87.4 63.3 58.2 74.3 51.2 97.4 69.2 58.1 58.9 49.2 83.1 56.3 76.6 42.2 45.9 43.8 140.6
Colon and rectum
Mokrana beika (C67) 30.2 24.9 31.5 30.6 28.7 42.5 17.1 37.3 38.4 30.0 21.5 28.7 26.0 48.0 46.2 15.7 38.4 32.9 36.8
Bladder
eludac (C16) 20.1 12.6 28.0 25.9 20.3 32.8 23.5 23.7 25.2 16.5 15.9 15.4 15.6 16.6 21.7 22.6 37.4 24.1 32.5
Stomach
Larinks (C32) 17.8 17.8 4.7 22.5 18.3 16.4 14.2 15.3 23.1 13.6 18.1 23.6 19.0 11.6 22.3 16.7 12.2 21.9 28.1
Larynx
Usna uplj. i farinks (C00-C10) 12.7 15.1 9.3 21.8 9.1 9.7 14.2 11.0 10.5 10.7 5.7 7.2 13.8 14.9 9.8 6.9 16.8 13.1 13.0
Mouth and pharynx
Pankreas (C25) 12.5 6.2 12.8 20.4 17.6 10.6 19.2 11.0 20.3 4.8 15.9 17.4 32.9 21.5 12.0 2.9 11.2 13.1 30.3
Pancreas
Mozak (C71) 12.2 9.1 18.7 9.5 13.1 9.7 13.5 16.1 20.3 4.8 13.6 17.4 12.1 11.6 11.4 14.7 15.9 6.6 23.8
Brain
Bubreg (C64) 11.4 8.8 16.3 17.0 11.8 15.4 12.1 10.2 16.8 9.7 10.2 13.3 8.7 18.2 12.5 4.9 10.3 6.6 17.3
Kidney
Jetra (C22) 9.1 2.8 11.7 16.3 11.8 12.6 5.7 1.7 7.7 5.8 18.1 19.5 12.1 26.5 12.0 7.9 10.3 11.0 32.5
Liver
Leukemije (C91-C95) 8.1 5.3 9.3 11.6 9.1 15.4 7.1 3.4 17.5 5.8 0.0 1.0 20.8 13.2 12.0 7.9 4.7 4.4 15.1
Leukaemias
Druge lokalizacije 149.0 172.5 195.8 119.1 120.2 134.2 128.8 166.1 199.8 172.4 107.6 138.3 147.2 139.0 122.9 72.6 109.5 107.4 214.2
Other sites
Sve lokalizacije (C00-C97) 539.2 589.0 600.3 528.9 436.5 565.8 461.0 586.3 627.4 466.9 427.0 513.3 580.0 524.7 545.8 327.8 491.3 453.6 770.3
All sites
Sve lokalizacije bez koe (C44) 476.1 515.0 519.9 471.0 383.5 481.8 392.7 491.4 559.7 368.1 398.7 457.0 541.9 451.9 518.6 304.2 448.2 425.1 703.2
Tabela 8. Stope incidencije od raka na 100.000 stanovnika prema vodeim lokalizacijama i okruzima, ene,
Table 8. Cancer incidence rates per 100.000 population by leading primary sites, females, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd
Pomoravski

Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Dojka (C50) 117.7 154.3 124.8 82.3 70.7 115.4 94.0 165.8 121.5 88.5 76.0 83.7 94.0 98.1 121.8 69.7 77.3 86.5 119.6
Breast
Kolon i rektum (C18-C20) 50.9 42.3 78.7 39.8 44.2 61.3 34.5 84.8 60.2 45.0 53.1 38.6 74.9 49.1 68.0 32.6 43.0 37.3 121.9
Colon and rectum
Grli materice (C53) 36.4 43.8 28.6 13.4 20.6 40.9 32.7 32.0 41.0 26.5 33.2 31.9 42.9 45.9 40.4 50.8 27.0 31.1 35.4
Cervix uteri
Plua i bronh (C34) 35.4 39.9 53.8 36.1 21.8 40.0 29.2 27.1 51.0 21.9 36.4 50.8 36.3 28.5 28.9 15.9 33.5 26.6 26.6
Lung and bronchus
Materica (C54) 26.7 31.5 19.5 14.0 25.1 21.4 8.4 32.8 22.2 18.3 30.0 28.9 29.7 28.5 32.0 20.9 40.1 13.3 37.7
Corpus uteri
Ovarijum (C56) 16.7 12.2 27.5 13.4 12.2 16.7 16.0 20.5 18.1 8.2 19.3 14.9 14.8 49.1 23.6 11.0 23.3 26.6 33.2
Ovary
Pankreas (C25) 10.0 5.7 20.6 8.0 7.1 9.3 13.9 8.2 20.8 3.7 9.6 8.0 14.8 9.5 13.7 7.0 14.0 33.3 24.4
Pancreas
Mokrana beika (C67) 9.7 9.4 4.6 10.7 8.4 12.1 7.0 16.4 11.4 11.0 11.8 13.9 11.5 12.7 11.6 3.0 3.7 6.7 6.6
Bladder
Mozak (C71) 9.6 8.0 14.9 2.7 8.4 9.3 16.7 12.3 14.1 5.5 9.6 9.0 9.9 7.9 10.5 5.0 14.9 17.7 15.5
Brain
eludac (C16) 9.4 5.2 13.7 10.0 6.4 15.8 10.4 12.3 12.1 6.4 12.9 8.0 8.2 22.2 8.4 10.0 21.4 13.3 13.3
Stomach
Jetra (C22) 6.8 1.7 6.9 12.7 12.8 9.3 6.3 10.7 4.0 1.8 7.5 10.0 4.9 12.7 15.2 3.0 6.5 8.9 31.0
Liver
Leukemije (C91-C95) 5.8 4.4 12.6 6.0 3.9 13.0 7.7 1.6 11.4 5.5 0.0 0.0 8.2 3.2 7.9 1.0 6.5 17.7 11.1
Leukaemias
Other sites
All sites
Tabela 9. Standardizovane stope incidencije od raka na 100.000 stanovnika prema vodeim lokalizacijama i okruzima, mukarci,
Table 9. Standardized cancer incidence rates per 100.000 population by leading primary sites, males, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd
Pomoravski
Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Plua i bronh, (C34) 65.0 91.8 66.0 61.2 42.8 61.1 57.1 52.5 54.2 45.9 48.3 71.8 50.1 34.3 58.3 53.3 47.4 55.0 50.6
Lung and bronchus
Prostata (C61) 30.0 41.8 16.5 23.7 25.9 26.7 15.9 33.0 33.0 17.1 17.7 23.8 25.5 29.8 30.8 17.8 35.9 22.2 23.9
Prostate
Kolon i rektum (C18-C20) 34.6 39.0 41.6 32.2 35.7 36.5 23.5 47.6 35.4 25.5 26.7 27.8 34.5 26.8 34.8 28.5 23.4 21.9 55.5
Colon and rectum
Mokrana beika (C67) 15.1 13.6 13.5 15.7 17.0 18.6 9.0 17.8 18.9 12.4 8.8 13.8 10.7 20.1 21.5 10.2 18.9 15.9 16.5
Bladder
eludac (C16) 10.2 7.3 13.5 12.7 12.4 15.5 11.4 10.2 12.2 8.6 7.6 8.6 5.4 7.9 9.4 15.2 16.8 11.0 12.1
Stomach
Larinks (C32) 10.1 10.7 2.3 12.5 11.1 9.6 8.3 7.8 12.5 7.8 10.3 14.0 9.3 4.8 12.4 11.7 6.2 11.1 12.0
Larynx
Usna uplj. i farinks (C00-C10) 7.0 8.9 5.7 12.6 5.6 5.5 8.5 4.5 5.3 4.8 3.9 3.4 6.2 6.9 5.0 4.6 9.7 6.8 5.5
Mouth and pharynx
Pankreas (C25) 6.4 3.9 7.3 9.8 9.2 4.8 9.0 5.4 10.3 2.1 6.7 9.7 11.1 11.1 5.7 2.0 5.1 6.0 12.1
Pancreas
Mozak (C71) 8.4 8.5 10.0 6.6 8.6 5.6 6.0 9.3 12.0 2.2 11.5 10.2 6.8 7.4 7.8 12.4 9.4 6.7 12.6
Brain
Bubreg (C64) 6.5 4.9 7.9 10.2 7.5 9.0 7.7 4.8 8.9 7.1 7.8 7.7 3.7 12.3 5.6 3.5 6.0 4.7 11.3
Kidney
Jetra (C22) 4.6 1.4 6.1 8.3 7.2 5.8 3.1 1.2 3.9 2.6 9.9 8.8 4.8 14.3 4.5 4.8 5.3 5.2 12.3
Liver
Leukemije (C91-C95) 5.3 4.1 6.7 7.9 6.5 10.5 4.2 5.5 9.9 4.8 0.0 0.3 7.7 5.5 6.1 7.5 2.6 2.3 7.2
Leukaemias
Other sites
All sites
Tabela 10. Standardizovane stope incidencije od raka na 100.000 stanovnika prema vodeim lokalizacijama i okruzima, ene
Table 10. Standardized cancer incidence rates per 100.000 population by leading primary sites, females, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd
Pomoravski

Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Dojka (C50) 68.3 93.0 69.2 47.7 44.4 63.0 52.9 86.2 70.0 47.8 42.8 49.0 45.6 48.9 66.4 49.1 45.2 45.0 70.2
Breast
Kolon i rektum (C18-C20) 25.6 23.2 36.3 20.5 26.5 29.8 16.4 40.6 28.6 18.6 23.2 19.8 28.5 20.6 29.7 21.5 21.5 20.1 51.7
Colon and rectum
Grli materice (C53) 23.2 27.4 19.4 9.1 15.0 27.2 19.4 22.3 27.8 16.3 19.4 21.4 28.0 22.8 24.3 36.9 16.8 17.9 25.4
Cervix uteri
Plua i bronh (C34) 18.2 21.0 26.2 20.0 12.7 19.9 13.0 13.2 26.7 10.9 18.3 27.1 15.3 14.6 13.3 9.8 16.2 15.1 13.0
Lung and bronchus
Materica (C54) 13.8 17.0 8.4 6.8 14.1 10.9 3.8 17.2 10.9 8.1 16.9 16.2 10.7 13.1 15.9 12.0 22.6 8.0 19.7
Corpus uteri
Ovarijum (C56) 10.2 7.8 17.4 8.3 8.1 7.9 8.6 12.4 9.2 4.7 12.9 7.2 8.8 23.6 16.2 8.2 14.9 18.4 17.4
Ovary
Pankreas (C25) 4.4 3.0 8.7 3.6 3.0 4.3 5.3 3.0 9.1 1.4 3.5 3.8 3.8 4.0 5.5 4.4 6.1 10.9 8.5
Pancreas
Mokrana beika (C67) 4.4 4.3 2.1 4.3 4.2 5.0 2.9 8.0 4.2 5.6 3.8 7.9 5.1 6.4 5.3 1.2 1.2 3.2 3.0
Bladder
Mozak (C71) 6.8 8.2 7.6 1.3 5.2 7.4 8.6 6.0 7.3 3.1 5.5 5.5 9.3 5.4 7.2 3.8 8.4 9.2 6.9
Brain
eludac (C16) 4.2 2.7 5.0 4.2 2.7 7.3 4.9 4.8 5.7 3.0 5.9 3.9 2.0 9.2 3.0 5.0 8.7 6.7 6.0
Stomach
Jetra (C22) 2.7 0.7 1.9 5.6 6.4 3.8 2.2 5.3 1.3 0.8 2.0 4.0 2.2 3.2 6.0 1.3 2.3 4.0 8.3
Liver
Leukemije (C91-C95) 4.0 3.5 9.4 2.8 2.8 6.4 6.4 0.5 6.2 6.4 0.0 0.0 4.1 1.5 5.6 1.2 5.6 10.3 4.1
Leukaemias
Other sites
All sites
Tabela 11. Broj umrlih sluajeva od raka prema vodeim lokalizacijama i okruzima, mukarci,
Table 11. Number of death cancer cases by leading primary sites, males, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd
Pomoravski
Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Plua i bronh (C34) 2588 819 84 163 110 94 124 131 134 137 93 112 53 42 204 96 105 48 39
Lung and bronchus
Kolon i rektum (C18-C20) 1134 388 43 60 52 37 64 61 49 44 40 31 31 30 105 27 28 23 21
Colon and rectum
Prostata (C61) 758 230 18 33 37 42 51 35 40 29 26 31 20 19 53 27 37 19 11
Prostate
eludac (C16) 497 126 35 41 25 19 29 23 23 13 14 14 10 17 34 23 32 9 10
Stomach
Pankreas (C25) 441 154 10 31 27 12 25 16 23 25 14 20 16 7 21 10 18 4 8
Pancreas
Mokrana be{ika (C67) 418 172 18 23 17 13 18 9 12 18 16 15 9 6 36 13 9 6 8
Bladder
Jetra (C22) 283 76 14 18 15 17 6 9 7 13 8 15 6 10 24 16 12 5 12
Liver
Larinks (C32) 276 74 2 16 13 9 7 12 17 9 16 22 12 6 26 7 14 9 5
Larynx
Mozak (C71) 273 102 8 11 20 5 11 12 14 15 4 14 7 5 9 7 18 2 9
Brain
Leukemije (C91-C95) 232 81 6 10 13 12 11 10 8 9 16 8 6 5 15 9 7 2 4
Leukaemias
Ostale lokalizacije 1794 593 53 111 79 88 157 63 87 67 96 83 48 40 128 42 70 35 30
Other sites
All sites
Tabela 12. Broj umrlih sluajeva od raka prema vodeim lokalizacijama i okruzima, ene,
Table 12. Number of death cancer cases by leading primary sites, females, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd
Pomoravski

Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Dojka (C50) 1175 435 46 57 60 32 60 45 59 48 36 33 24 27 93 39 44 17 20

Breast
Plua i bronh (C34) 963 437 30 44 30 27 34 28 46 46 36 33 24 21 62 18 29 8 10
Lung and bronchus
Kolon i rektum (C18-C20) 732 273 25 41 26 19 35 45 30 22 27 19 31 19 59 14 23 10 14
Colon and rectum
Pankreas (C25) 386 133 14 12 13 18 23 15 33 18 11 11 11 7 26 3 14 13 11
Pancreas
Grli materice (C53) 334 81 8 19 23 11 24 17 25 11 25 21 5 15 25 6 7 6 5
Cervix uteri
eludac (C16) 311 115 12 12 11 11 11 10 9 10 13 17 3 10 21 13 23 8 2
Stomach
Ovarijum (C56) 294 84 12 12 12 20 17 13 14 9 11 13 4 17 21 5 14 4 12
Ovary
Jetra (C22) 233 60 7 9 16 12 9 13 4 7 5 10 6 12 27 16 7 2 11
Liver
Mozak (C71) 221 78 10 3 10 11 17 13 9 8 7 6 6 5 8 4 15 4 7
Brain
Materica, telo (C54) 174 42 7 8 8 8 5 11 10 18 10 3 4 3 19 1 14 2 4
Corpus uteri
Ostale lokalizacije 1714 639 58 87 79 58 81 92 78 65 72 75 46 41 123 33 40 28 16
Other sites
All sites
Tabela 13. Stope mortaliteta od raka na 100.000 stanovnika prema vodeim lokalizacijama i okruzima, mukarci,
Table 13. Cancer mortality rates per 100.000 population by leading primary sites, males, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd
Pomoravski
Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Plua i bronh (C34) 100.7 104.0 97.9 110.9 71.9 90.8 88.2 111.0 93.6 132.7 105.3 114.8 91.8 69.5 110.9 94.2 98.3 105.2 84.4
Lung and bronchus
Kolon i rektum (C18-C20) 44.1 49.3 50.1 40.8 34.0 35.7 45.5 51.7 34.2 42.6 45.3 31.8 53.7 49.7 57.1 26.5 26.2 50.4 45.4
Colon and rectum
Prostata (C61) 29.5 29.2 21.0 22.5 24.2 40.5 36.3 29.7 27.9 28.1 29.4 31.8 34.6 31.4 28.8 26.5 34.6 41.6 23.8
Prostate
eludac (C16) 19.3 16.0 40.8 27.9 16.3 18.3 20.6 19.5 16.1 12.6 15.9 14.3 17.3 28.1 18.5 22.6 29.9 19.7 21.6
Stomach
Pankreas (C25) 17.2 19.6 11.7 21.1 17.6 11.6 17.8 13.6 16.1 24.2 15.9 20.5 27.7 11.6 11.4 9.8 16.8 8.8 17.3
Pancreas
Mokra}na be{ika (C67) 16.3 21.8 21.0 15.7 11.1 12.6 12.8 7.6 8.4 17.4 18.1 15.4 15.6 9.9 19.6 12.8 8.4 13.1 17.3
Bladder
Jetra (C22) 11.0 9.7 16.3 12.3 9.8 16.4 4.3 7.6 4.9 12.6 9.1 15.4 10.4 16.6 13.0 15.7 11.2 11.0 26.0
Liver
Larinks (C32) 10.7 9.4 2.3 10.9 8.5 8.7 5.0 10.2 11.9 8.7 18.1 22.5 20.8 9.9 14.1 6.9 13.1 19.7 10.8
Larynx
Mozak (C71) 10.6 13.0 9.3 7.5 13.1 4.8 7.8 10.2 9.8 14.5 4.5 14.3 12.1 8.3 4.9 6.9 16.8 4.4 19.5
Brain
Leukemije (C91-C95) 9.0 10.3 7.0 6.8 8.5 11.6 7.8 8.5 5.6 8.7 18.1 8.2 10.4 8.3 8.2 8.8 6.6 4.4 8.7
Leukaemias
Ostale lokalizacije 69.8 75.3 61.8 75.6 51.6 85.0 111.7 53.4 60.8 64.9 108.7 85.0 83.1 66.2 69.6 41.2 65.5 76.7 64.9
Other sites
All sites
Tabela 14. Stope mortaliteta od raka na 100.000 stanovnika prema vodeim lokalizacijama i okruzima, ene,
Table 14. Cancer mortality rates per 100.000 population by leading primary sites, females, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd
Pomoravski

Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Dojka (C50) 43.4 49.6 52.7 57.0 38.5 29.8 41.8 36.9 39.6 43.8 38.6 32.9 39.6 42.7 48.8 38.8 41.0 37.7 44.3
Breast
Plua i bronh (C34) 35.6 49.8 34.4 29.4 19.3 25.1 23.7 23.0 30.9 42.0 38.6 32.9 39.6 33.2 32.6 17.9 27.0 17.7 22.2
Lung and bronchus
Kolon i rektum (C18-C20) 27.0 31.1 28.6 27.4 16.7 17.7 24.4 36.9 20.1 20.1 28.9 18.9 51.1 30.1 31.0 13.9 21.4 22.2 31.0
Colon and rectum
Pankreas (C25) 14.3 15.2 16.0 8.0 8.4 16.7 16.0 12.3 22.2 16.4 11.8 11.0 18.1 11.1 13.7 3.0 13.0 28.8 24.4
Pancreas
Grli materice (C53) 12.3 9.2 9.2 12.7 14.8 10.2 16.7 14.0 16.8 10.0 26.8 20.9 8.2 23.7 13.1 6.0 6.5 13.3 11.1
Cervix uteri
eludac (C16) 11.5 13.1 13.7 8.0 7.1 10.2 7.7 8.2 6.0 9.1 13.9 16.9 4.9 15.8 11.0 12.9 21.4 17.7 4.4
Stomach
Ovarijum (C56) 10.9 9.6 13.7 8.0 7.7 18.6 11.8 10.7 9.4 8.2 11.8 13.0 6.6 26.9 11.0 5.0 13.0 8.9 26.6
Ovary
Jetra (C22) 8.6 6.8 8.0 6.0 10.3 11.2 6.3 10.7 2.7 6.4 5.4 10.0 9.9 19.0 14.2 15.9 6.5 4.4 24.4
Liver
Mozak (C71) 8.2 8.9 11.5 2.0 6.4 10.2 11.8 10.7 6.0 7.3 7.5 6.0 9.9 7.9 4.2 4.0 14.0 8.9 15.5
Brain
Materica, telo (C54) 6.4 4.8 8.0 5.3 5.1 7.4 3.5 9.0 6.7 16.4 10.7 3.0 6.6 4.7 10.0 1.0 13.0 4.4 2.2
Corpus uteri
Other sites
All sites
Tabela 15. Standardizovane stope mortaliteta od raka na 100.000 stanovnika prema vodeim lokalizacijama i okruzima, mukarci
Table 15. Standardized cancer mortality rates per 100.000 population by leading primary sites, males, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd
Pomoravski
Podunavski
Branievski
umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Plua i bronh (C34) 51.6 56.4 48.4 56.6 43.1 40.4 42.7 52.2 46.4 58.6 52.2 60.9 36.8 31.2 57.8 60.1 50.7 52.3 38.7
Lung and bronchus
Kolon i rektum (C18-C20) 20.1 23.4 21.4 20.7 19.1 16.3 19.9 22.5 15.8 15.6 18.4 15.9 17.8 20.6 24.8 15.3 12.0 23.9 14.8
Colon and rectum
Prostata (C61) 11.4 12.1 7.3 9.1 11.4 13.6 13.3 11.9 11.2 9.1 9.9 12.7 9.4 10.7 10.4 14.4 13.1 13.6 8.7
Prostate
eludac (C16) 9.2 7.9 18.5 13.5 9.9 8.1 9.6 7.6 8.5 6.3 7.6 7.1 8.1 12.7 7.8 13.6 13.8 8.0 8.4
Stomach
Pankreas (C25) 8.1 9.8 5.7 9.8 8.9 5.6 7.7 6.3 7.4 10.0 6.5 11.2 10.2 5.3 5.0 5.7 8.7 5.0 5.5
Pancreas
Mokrana beika (C67) 7.1 10.0 7.4 6.9 6.9 4.8 5.5 3.2 3.5 6.0 5.8 7.1 5.7 5.0 8.7 7.0 3.2 6.3 8.0
Bladder
Jetra (C22) 5.1 5.0 6.9 6.1 5.2 6.3 1.9 3.2 2.1 6.3 5.2 6.7 4.0 7.3 4.9 9.1 5.2 4.5 9.7
Liver
Larinks (C32) 5.5 4.8 1.1 5.7 5.6 3.9 2.2 4.8 6.0 4.5 8.9 12.8 7.9 4.9 7.5 4.5 6.6 8.6 4.4
Larynx
Mozak (C71) 6.5 8.4 5.1 7.1 8.5 3.5 4.8 4.7 5.2 8.1 2.2 8.0 5.4 4.7 2.7 4.9 9.1 2.8 7.5
Brain
Leukemije (C91-C95) 4.9 6.0 3.0 4.2 5.9 5.5 4.1 3.2 3.0 4.0 8.1 4.1 2.9 3.6 3.6 7.4 3.5 2.3 4.0
Leukaemias
Other sites
All sites
Tabela 16. Standardizovane stope mortaliteta od raka na 100.000 stanovnika prema vodeim lokalizacijama i okruzima, ene,
Table 16. Standardized cancer mortality rates per 100.000 population by leading primary sites, females, regions in Central Serbia, 2012
centralna Srbija
Grad Beograd
Pomoravski
Podunavski
Branievski

umadijski
Kolubarski
Mavanski
Zlatiborski
Zajearski
Jablaniki
Moraviki
Rasinski
Niavski
Pinjski
Topliki
Pirotski
Borski
Raki
Dojka (C50) 20.2 22.8 18.7 16.4 22.7 11.4 18.7 16.8 21.3 19.3 15.5 15.7 17.5 18.1 24.2 23.7 19.4 17.2 23.5
Breast
Plua i bronh (C34) 17.1 23.9 14.6 15.5 10.8 11.7 11.7 10.3 14.5 16.7 19.9 16.6 18.6 19.1 14.7 10.7 14.1 7.5 14.2
Lung and bronchus
Kolon i rektum (C18-C20) 10.5 11.8 11.6 12.4 9.0 6.7 9.9 14.5 7.8 7.5 9.4 9.5 17.1 10.0 9.6 6.1 8.1 12.1 10.0
Colon and rectum
Pankreas (C25) 5.4 5.9 6.9 3.1 3.5 5.4 6.0 3.3 9.3 5.9 4.2 5.1 5.2 4.8 5.4 1.3 5.2 7.1 8.9
Pancreas
Grli materice (C53) 6.4 4.6 4.4 6.9 9.4 6.4 8.4 6.3 8.8 3.8 14.2 10.8 4.1 11.8 7.0 3.9 3.9 5.2 3.8
Cervix uteri
eludac (C16) 4.4 4.9 4.3 2.7 3.4 5.2 3.4 4.2 2.4 3.7 4.8 7.6 0.7 5.4 4.0 6.0 7.3 8.3 1.5
Stomach
Ovarijum (C56) 5.3 4.9 7.4 4.5 4.0 8.7 5.3 4.4 4.3 3.7 5.7 5.6 2.4 11.5 5.4 2.5 6.6 4.9 9.6
Ovary
Jetra (C22) 3.3 2.5 2.8 2.6 4.6 5.3 2.6 4.9 0.9 2.1 1.9 4.0 5.0 5.1 4.7 7.9 2.3 1.1 6.9
Liver
Mozak (C71) 4.3 5.0 5.8 0.9 3.5 4.9 4.8 5.5 3.8 3.2 6.2 2.7 5.8 5.4 2.3 1.5 7.5 4.5 5.5
Brain
Materica, telo (C54) 2.8 2.5 3.3 2.8 4.6 5.3 2.6 4.9 0.9 2.1 1.9 4.0 5.0 5.1 4.7 7.9 2.3 1.1 6.9
Corpus uteri
Other sites
All sites
Tabela 17. Ukupan broj novoobolelih i broj novoobolelih od raka sa procentom registrovanih samo na
osnovu prijave smrti, prema primarnoj lokalizaciji i polu, centralna Srbija, 2012. godina
Table 17. Total number of new cancer cases and number and percentage of cases registered from death certificates only,
by primary site and sex, Central Serbia, 2012
MKB-10 POL Ukupno Broj registrovanih samo na osnovu prijave smrti

Number of cases registered from death certificates only %
(ICD-10) Primarna lokalizacija Primary SEX (All )
ifra (Code ) site M (Male) 13860 742 5.4%
Ukupno (All ) (Female) 12358 572 4.6%
C00 Usna M 77 2 2.6%
Lip 21 0 0.0%
C01 Jezik, koren M 23 0 0.0%
Base of tongue 6 0 0.0%
C02 Jezik, drugi delovi M 40 0 0.0%
Tongue, other & unspecified parts 11 0 0.0%
C03 Desni M 6 0 0.0%
Gum 2 0 0.0%
C04 Pod usta M 49 1 2.0%
Floor of mouth 14 0 0.0%
C05 Nepce M 17 1 5.9%
Palate 2 0 0.0%
C06 Usta, drugi delovi M 12 0 0.0%
Mouth, other & unspecified parts 33 0 0.0%
C07 Parotidna lezda M 21 1 4.8%
Parotid gland 14 0 0.0%
C08 Pljuvana lezda M 12 0 0.0%
Other & unspec. major salivary gl. 11 0 0.0%
C09 Krajnik M 32 0 0.0%
Tonsil 8 1 12.5%
C10 Orofarings M 37 0 0.0%
Oropharynx 25 0 0.0%
C11 Nasofarings M 54 2 3.7%
Nasopharynx 12 0 0.0%
C12 Piriformni sinus M 4 0 0.0%
Pyriform sinus 0 0 0.0%
C13 Hipofarings M 74 1 1.4%
Hypopharynx 8 1 12.5%
C14 Usne, usta, drelo, drugi delovi M 18 0 0.0%
Other and ill def. sites in the lip, oral cavity & pharynx 13 0 0.0%
C15 Jednjak M 167 7 4.2%
Oesophagus 24 3 12.5%
C16 eludac M 517 37 7.2%
Stomach 255 63 24.7%
C17 Tanko crevo M 32 0 0.0%
Small intestine 26 1 3.8%
C18 Debelo crevo M 986 59 6.0%
Colon 605 16 2.6%
C19 Rektosigmoidni prelaz M 112 10 8.9%
Rectosigmoid junction 95 3 3.2%
C20 Rektum M 623 29 4.7%
Rectum 353 20 5.7%
C21 Anus i analni kanal M 21 0 0.0%
Anus & anal canal 8 0 0.0%
C22 Jetra, uni kanali M 233 39 16.7%
Liver & intrahepatic bile ducts 185 45 24.3%
C23 una kesa M 28 3 10.7%
Gallbladder 73 4 5.5%
C24 uni kanali, drugi delovi M 18 2 11.1%
Billiary tract, other & unspec. parts 33 1 3.0%
C25 Pankreas M 322 32 9.9%
Pancreas 272 29 10.7%
C26 Organi za varenje, nedovoljno odredjene lokalizacije M 19 2 10.5%
Other & ill-defined digestive organs 24 1 4.2%
C30 Nosna upljina i srednje uvo M 20 0 0.0%
Nasal cavity & middle ear 12 1 8.3%
C31 Nosni sinusi M 23 1 4.3%
Accessory sinuses 6 0 0.0%
C32 Larings M 458 8 1.7%
Larynx 54 2 3.7%
C33 Traheja M 6 0 0.0%
Trachea 2 0 0.0%
C34 Bronh i plua M 3117 321 10.3%
Bronchus & lung 959 121 12.6%
C37 Timus M 0 0 0.0%
Thymus 0 0 0.0%
C38 Srce, mediastinum, pleura M 44 2 4.5%
Heart, mediastinum & pleura 17 1 5.9%
C39 Toraks, druge lokalizacije M 2 0 0.0%
Other & ill-def. in the res.sys. 2 0 0.0%
C40 Kosti i zglobne hrskavice udova M 53 0 0.0%
Bone & articular cartilage of limbs 43 0 0.0%
C41 Kosti i zglobne hrskavice, druge lokalizacije M 32 4 12.5%
Bone & articular cartilage of other 32 5 15.6%
C43 Koa, maligni melanom M 241 4 1.7%
Malignant melanoma of skin 220 3 1.4%
C44 Koa, drugi maligni tumori M 1622 10 0.6%
Skin, other malignomas 1507 14 0.9%
C45 Mezoteliom M 8 0 0.0%
Mesothelioma 2 0 0.0%
C46 Kaposijev sarkom M 2 0 0.0%
Kaposi's sarcoma 3 0 0.0%
C47 Periferni nervi i autonomni nervni sistem M 9 0 0.0%
Peripheral nerves & auton. nerv. sys. 9 0 0.0%
C48 Peritoneum i retroperitoneum M 26 4 15.4%
Retroperitoneum & peritoneum 34 4 11.8%
C49 Vezivna i meka tkiva, drugi M 65 1 1.5%
Other connective and soft tissue 88 1 1.1%
C50 Dojka M 61 1 1.6%
Breast 3186 118 3.7%
Tabela 17.1 Ukupan broj novoobolelih i broj novoobolelih od raka sa procentom registrovanih samo na
osnovu prijave smrti, prema primarnoj lokalizaciji i polu, centralna Srbija, 2012. godina (nastavak)
Table 17.1 Total number of new cancer cases and number and percentage of cases registered from death certificates only,
by primary site and sex, Central Serbia, 2012 (continued)
MKB-10 POL Ukupno Broj registrovanih samo na osnovu prijave smrti

Number of cases registered from death certificates only %
(ICD-10) Primarna lokalizacija Primary SEX (All )
ifra (Code ) site M (Male ) 13860 742 5.4%
Ukupno (All ) (Female ) 12358 572 4.6%
C51 Vulva 80 4 5.0%
Vulva
C52 Vagina 25 1 4.0%
Vagina
C53 Grli materice 986 10 1.0%
Cervix uteri
C54 Materica, telo 722 4 0.6%
Corpus uteri
C55 Materica, neoznaeni deo 22 2 9.1%
Uterus, unspecified part
C56 Jajnik 453 12 2.6%
Ovary
C57 enski genitalni organi, drugi neoznaeni organi 20 0 0.0%
Other & unspec.parts of fem. gen.org.
C58 Placenta 0 0 0.0%
Placenta
C60 Penis M 44 1 2.3%
Penis
C61 Prostata M 1748 42 2.4%
Prostate
C62 Testis M 196 4 2.0%
Testis
C63 Muki genitalni organi, drugi neoznaeni organi M 5 0 0.0%
Other & unspec. male genital organs
C64 Bubreg M 293 8 2.7%
Kidney, except renal pelvis 168 9 5.4%
C65 Bubrena karlica M 23 0 0.0%
Renal pelvis 11 0 0.0%
C66 Ureter M 14 1 7.1%
Ureter 13 0 0.0%
C67 Mokrana beika M 775 19 2.5%
Bladder 262 5 1.9%
C68 Urinarni organi, drugi neoznaeni organi M 2 0 0.0%
Other & unspecified urinary organs 9 0 0.0%
C69 Oko, pripoji oka M 25 1 4.0%
Eye and adnexa 30 0 0.0%
C70 Modanice M 18 0 0.0%
Meninges 21 0 0.0%
C71 Mozak M 314 20 6.4%
Brain 261 20 7.7%
C72 Centralni nervni sistem, drugi delovi M 12 2 16.7%
Spinal cord, cran. nerv. & oth. parts of CNS 2 1 50.0%
C73 titasta lezda M 63 0 0.0%
Thyroid gland 161 3 1.9%
C74 Nadbubrena lezda M 11 1 9.1%
Adrenal gland 16 1 6.3%
C75 Endokrine lezde, druge M 10 0 0.0%
Other endocrine glands & related structures 5 0 0.0%
C76 Ostale lokalizacije M 48 8 16.7%
Other & ill defined sites 53 10 18.9%
C77-C80 Sekundarne lokalizacije, bez oznaene lokalizacije M 314 22 7.0%
Unspec.mal.neo. of lymph nod.& without of spec.of site 209 16 7.7%
C81 Hodgkinova bolest M 69 2 2.9%
Hodgkin's disease 56 0 0.0%
C82 Folikularni ne-Hodgkinov limfom M 40 1 2.5%
Follicular non-Hodgkin's lymphoma 62 0 0.0%
C83 Difuzni ne-Hodgkinov limfom M 113 3 2.7%
Diffuse non-Hodgkin's lymphoma 94 0 0.0%
C84 Periferni i koni limfom T-elija M 4 0 0.0%
Peripheral & cutaneous T-cell lymphomas 5 0 0.0%
C85 Ne-Hodgkinovi limfomi, drugi M 73 3 4.1%
Other & unspecified types of non-Hodgkin's lymphoma 61 3 4.9%
C88 Zloudne imunoproliferativne bolesti M 8 0 0.0%
Malignant immunoproliferative diseases 6 0 0.0%
C90 Multipli mijelom i drugi zloudni tumori plazma elija M 85 8 9.4%
Multiple myeloma and malignant plasma cell neoplasms 78 5 6.4%
C91 Limphoidna leukemija M 106 4 3.8%
Lymphoblastic, lymphoid leukaemia 76 5 6.6%
C92 Mijeloidna leukemija M 86 3 3.5%
Myeloid leukaemia 69 1 1.4%
C93 Monocitna leukemija M 3 1 33.3%
Monocytic leukaemia 4 0 0.0%
C94 Leukemije, druge M 1 0 0.0%
Other leukaemias of specified cells 1 0 0.0%
C95 Leukemije, neoznaene M 11 4 36.4%
Leukaemia, unspecified cell type 8 2 25.0%
C96 Drugi zloudni tumori hematopoeznog sistema M 3 0 0.0%
Oth.&unspec.mal.neo. of lymph.,haematopoietic & related tissue 0 0 0.0%
C00-C96 Sve lokalizacije, bez koe M 12238 732 6.0%
(C44) All sites but skin 10851 558 5.1%
Tabela 18. Broj novoobolelih sluajeva od raka, prema primarnoj lokalizaciji (MKB-10), uzrastu i polu,
Table 18. Number of new cancer cases by primary site (ICD-10), age and sex, Central Serbia, 2012
POL Ukupno U Z R A S T (A g e )
Primarna lokalizacija SEX (All ) 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ %
Primary site M (Male ) 13860 22 23 39 41 75 97 130 170 247 449 1053 1827 2267 1922 2256 3242
100.0%
(Female ) 12358 22 25 13 39 45 85 204 295 545 802 1220 1699 1828 1416 1560 2560
Usna M 77 0 0 1 0 0 0 1 1 1 2 6 10 17 12 9 17 0.3%
Lip 21 0 0 0 0 0 0 0 0 0 0 0 1 3 3 4 10 0.1%
Jezik, koren M 23 0 0 0 0 0 0 0 0 1 1 7 9 2 0 2 1 0.1%
Base of tongue 6 0 0 0 0 0 0 0 0 1 0 0 2 1 1 1 0 0.0%
Jezik, drugi delovi M 40 0 0 0 0 0 0 0 0 0 1 8 16 9 3 0 3 0.2%
Tongue, other & unspecified parts 11 0 0 0 0 0 0 0 0 1 2 0 1 0 1 3 3 0.1%
Desni M 6 0 0 0 0 0 0 0 0 0 0 1 3 1 0 0 1 0.0%
Gum 2 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0.0%
Pod usta M 49 0 0 0 0 0 0 0 1 3 2 10 8 11 4 2 8 0.2%
Floor of mouth 14 0 0 0 0 0 1 0 1 0 0 2 0 4 2 2 2 0.1%
Nepce M 17 0 0 0 0 0 1 0 0 0 3 3 2 4 2 1 1 0.1%
Palate 2 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0.1%
Usta, drugi delovi M 12 0 0 0 0 0 0 0 0 0 0 2 1 2 0 2 5 0.1%
Mouth, other & unspecified parts 33 0 0 0 0 1 1 2 7 5 6 2 3 0 1 1 4 0.1%
Parotidna lezda M 21 0 0 0 0 0 0 1 0 2 1 0 2 5 2 3 5 0.1%
Parotid gland 14 0 0 0 0 0 0 0 0 1 1 1 2 2 1 4 2 0.1%
Pljuvana lezda M 12 0 0 0 0 0 0 0 0 0 0 0 0 0 5 1 6 0.0%
Other & unspec. major salivary gl. 11 0 0 0 0 0 0 0 0 1 0 1 3 0 1 1 4 0.1%
Krajnik M 32 0 0 0 0 0 0 0 0 1 0 2 9 5 3 5 7 0.2%
Tonsil 8 0 0 0 0 0 0 0 0 0 0 0 1 0 2 2 3 0.0%
Orofarings M 37 0 0 0 0 0 0 0 0 2 3 6 9 9 7 0 1 0.2%
Oropharynx 25 0 0 0 0 0 0 0 0 0 0 1 10 4 0 5 5 0.0%
Nasofarings M 54 0 0 0 0 6 3 0 3 3 7 11 7 8 0 2 4 0.2%
Nasopharynx 12 0 0 0 1 0 0 0 0 0 1 1 0 2 1 3 3 0.1%
Piriformni sinus M 4 0 0 0 0 0 0 0 0 0 0 0 0 1 0 3 0 0.0%
Pyriform sinus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
Hipofarings M 74 0 0 0 0 0 0 0 0 0 4 11 20 14 16 3 6 0.5%
Hypopharynx 8 0 0 0 0 0 0 0 0 0 1 2 3 1 0 1 0 0.1%
Usne, usta, drelo, drugi delovi M 18 0 0 0 0 0 0 0 0 0 0 3 3 3 4 0 5 0.1%
Other and ill def. sites in the lip, oral cavity & pharynx 13 0 0 0 0 0 0 0 0 0 0 6 1 0 1 1 4 0.0%
Jednjak M 167 0 0 0 0 0 0 0 3 2 10 18 28 42 15 24 25 1.3%
Oesophagus 24 0 0 0 0 0 0 0 0 2 2 2 2 1 4 6 5 0.3%
eludac M 517 0 0 0 0 0 0 0 7 13 16 34 69 78 73 94 133 4.4%
Stomach 255 0 0 0 0 0 1 3 2 3 6 19 27 29 39 51 75 2.6%
Tanko crevo M 32 0 0 0 0 0 0 0 0 0 3 1 3 5 6 2 12 0.2%
Small intestine 26 0 0 0 0 0 0 0 1 1 0 2 2 5 4 5 6 0.3%
Debelo crevo M 986 0 0 0 0 3 2 1 3 14 24 78 125 160 176 188 212 6.3%
Colon 605 0 0 0 0 1 3 5 8 17 32 46 72 105 78 92 146 5.3%
Rektosigmoidni prelaz M 112 0 0 0 0 0 0 0 4 1 7 8 11 14 21 21 25 0.5%
Rectosigmoid junction 95 0 0 0 0 0 0 0 1 1 3 8 9 17 14 18 24 0.4%
Rektum M 623 0 0 0 0 0 1 5 7 14 18 38 95 93 94 98 160 3.8%
Rectum 353 0 0 0 0 0 2 1 2 9 8 19 40 48 46 64 114 2.4%
Anus i analni kanal M 21 0 0 0 0 0 0 0 1 1 2 0 4 3 2 3 5 0.1%
Anus & anal canal 8 0 0 0 0 0 0 0 0 0 0 1 2 2 0 1 2 0.0%
Jetra, uni kanali M 233 0 0 1 0 2 1 0 3 1 6 13 23 36 30 52 65 1.8%
Liver & intrahepatic bile ducts 185 0 0 0 0 0 0 1 0 4 3 8 11 20 24 38 76 1.2%
una kesa M 28 0 0 0 0 0 0 0 0 0 1 5 2 3 5 3 9 0.2%
Gallbladder 73 0 0 0 0 0 0 0 0 2 1 1 7 10 10 15 27 0.5%
uni kanali, drugi delovi M 18 0 0 0 0 0 0 0 0 0 0 0 2 7 2 2 5 0.3%
Billiary tract, other & unspec. parts 33 0 0 0 0 0 0 0 0 0 6 2 2 7 4 3 9 0.2%
Pankreas M 322 0 0 0 0 1 0 1 1 5 13 33 44 46 40 47 91 3.0%
Pancreas 272 0 0 0 0 0 2 1 0 6 11 10 25 45 37 40 95 2.5%
Organi za varenje, nedovoljno odredjene lokalizacije M 19 0 0 0 0 0 0 0 0 1 0 1 3 2 1 5 6 0.1%
Other & ill-defined digestive organs 24 0 0 0 0 0 0 0 0 0 1 0 1 1 1 5 15 0.3%
Nosna upljina i srednje uvo M 20 0 0 1 0 0 0 1 1 0 0 3 2 3 5 0 4 0.1%
Nasal cavity & middle ear 12 0 0 0 0 0 0 0 0 1 1 0 0 1 4 1 4 0.1%
Nosni sinusi M 23 0 0 0 0 0 0 0 0 0 0 10 4 2 2 4 1 0.0%
Accessory sinuses 6 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 3 0.1%
Larings M 458 0 0 0 1 0 0 1 0 12 37 41 95 87 73 57 54 3.5%
Larynx 54 0 0 0 0 0 0 0 0 2 4 3 11 13 7 4 10 0.7%
Traheja M 6 0 0 0 0 0 0 0 0 0 0 0 0 3 0 1 2 0.0%
Trachea 2 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0.0%
Bronh i plua M 3117 0 0 0 0 0 3 6 10 37 113 315 596 658 465 447 467 25.6%
Bronchus & lung 959 0 0 0 0 1 0 2 11 16 64 105 186 173 121 118 162 7.8%
Timus M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
Thymus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
Srce, mediastinum, pleura M 44 0 0 0 0 2 0 2 0 2 4 3 9 6 4 8 4 0.2%
Heart, mediastinum & pleura 17 0 0 0 0 0 0 0 0 0 1 2 1 2 4 4 3 0.2%
Toraks, druge lokalizacije M 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0.0%
Other & ill-def. in the res.sys. 2 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0.0%
Kosti i zglobne hrskavice udova M 53 0 7 12 6 4 1 1 2 3 1 2 3 4 1 3 3 0.3%
Bone & articular cartilage of limbs 43 0 3 6 13 1 2 1 2 0 3 1 1 4 0 4 2 0.3%
Kosti i zglobne hrskavice, druge lokalizacije M 32 1 2 0 1 2 1 0 0 2 1 4 5 5 0 4 4 0.3%
Bone & articular cartilage of other 32 1 0 0 3 0 1 1 0 1 1 2 1 7 2 5 7 0.2%
Koa, maligni melanom M 241 0 0 0 0 0 0 8 6 10 12 13 44 29 32 38 49 1.9%
Malignant melanoma of skin 220 0 0 0 2 1 3 7 7 21 17 17 27 16 28 26 48 2.1%
Koa, drugi maligni tumori M 1622 0 0 1 3 2 5 14 12 23 45 79 130 227 231 285 565 11.3%
Skin, other malignomas 1507 0 0 0 1 1 6 18 21 24 39 69 120 192 223 261 532 11.7%
Mezoteliom M 8 0 0 0 0 0 0 0 0 0 0 1 1 1 1 2 2 0.0%
Mesothelioma 2 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0.0%
Kaposijev sarkom M 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0.0%
Kaposi's sarcoma 3 1 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0.0%
Periferni nervi i autonomni nervni sistem M 9 2 0 0 0 1 0 1 0 0 1 1 0 0 1 1 1 0.1%
Peripheral nerves & auton. nerv. sys. 9 0 0 0 0 0 0 0 0 1 0 0 4 0 1 2 1 0.0%
Peritoneum i retroperitoneum M 26 0 0 0 0 0 0 1 4 1 0 2 2 5 2 3 6 0.2%
Retroperitoneum & peritoneum 34 0 0 0 0 0 0 1 0 1 3 9 6 5 1 3 5 0.3%
Vezivna i meka tkiva, drugi M 65 0 0 0 1 6 1 6 6 3 6 6 8 11 2 4 5 0.6%
Other connective and soft tissue 88 1 0 1 0 1 1 3 4 8 4 15 20 5 5 7 13 0.6%
Dojka M 61 0 0 0 0 0 0 1 4 1 1 3 10 8 10 11 12 0.4%
Breast 3186 0 0 0 1 3 19 46 101 201 309 421 519 501 347 285 433 25.7%
Tabela 18.1 Broj novoobolelih sluajeva od raka, prema primarnoj lokalizaciji (MKB-10), uzrastu i polu,
centralna Srbija,2012.godina (nastavak)
Table 18.1 Number of new cancer cases by primary site (ICD-10), age and sex, Central Serbia, 2012 (continued)
MKB-10 POL Ukupno U Z R A S T (A g e)

(ICD-10) Primarna lokalizacija SEX (All) 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ %
ifra (Code ) Primary site M (Male ) 13860 22 23 39 41 75 97 130 170 247 449 1053 1827 2267 1922 2256 3242
100.0%
Ukupno (All ) (Female ) 12358 22 25 13 39 45 85 204 295 545 802 1220 1699 1828 1416 1560 2560
C51 Vulva 80 0 0 0 0 0 0 0 3 2 1 2 5 9 6 14 38 0.6%
Vulva
C52 Vagina 25 0 0 0 0 0 0 0 0 2 2 1 4 3 4 3 6 0.2%
Vagina
C53 Grli materice 986 0 0 0 0 2 11 43 54 100 102 152 148 128 69 76 101 8.0%
Cervix uteri
C54 Materica, telo 722 0 0 1 0 1 1 7 10 18 30 85 151 130 88 90 110 5.8%
Corpus uteri
C55 Materica, neoznaeni deo 22 0 0 0 0 0 0 0 1 1 2 3 0 7 1 3 4 0.2%
C56 Jajnik 453 0 1 0 1 8 9 8 26 29 35 49 52 74 49 49 63 3.7%
Ovary
C57 enski genitalni organi, drugi neoznaeni organi 20 0 0 0 0 0 0 1 1 0 2 0 2 4 0 3 7 0.2%
C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
Placenta
C60 Penis M 44 0 0 1 0 0 0 0 1 1 1 4 5 10 4 3 14 0.3%
Penis
C61 Prostata M 1748 0 0 0 0 0 0 0 0 0 1 32 108 213 261 445 688 12.6%
Prostate
C62 Testis M 196 0 0 1 5 24 41 41 32 19 7 11 7 4 2 2 0 1.4%
Testis
C63 Muki genitalni organi, drugi neoznaeni organi M 5 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 1 0.0%
C64 Bubreg M 293 3 0 0 1 0 0 4 7 9 11 32 44 61 33 44 44 2.1%
Kidney, except renal pelvis 168 0 1 0 1 2 2 2 4 6 10 11 26 22 11 29 41 1.4%
C65 Bubrena karlica M 23 0 0 0 0 0 1 0 1 0 0 0 4 7 1 5 4 0.2%
Renal pelvis 11 0 0 0 0 0 0 0 1 0 1 1 1 2 3 0 2 0.1%
C66 Ureter M 14 0 0 0 0 0 0 0 0 0 2 0 2 2 4 3 1 0.1%
Ureter 13 0 0 0 0 0 0 0 0 0 0 2 0 2 1 3 5 0.1%
C67 Mokrana beika M 775 0 0 0 0 0 2 3 7 13 24 58 83 120 110 123 232 5.6%
Bladder 262 0 0 0 0 1 0 2 0 3 7 28 27 48 27 39 80 2.1%
C68 Urinarni organi, drugi neoznaeni organi M 2 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0.0%
Other & unspecified urinary organs 9 0 0 0 0 0 0 0 0 0 0 0 0 2 2 4 1 0.1%
C69 Oko, pripoji oka M 25 1 0 0 0 0 1 0 0 1 0 2 2 7 2 4 5 0.2%
Eye and adnexa 30 1 0 0 0 0 0 1 0 0 2 2 3 6 3 5 7 0.2%
C70 Modanice M 18 0 0 0 0 0 0 0 1 1 1 2 2 1 3 4 3 0.1%
Meninges 21 0 0 0 0 0 0 0 1 1 1 0 5 3 4 2 4 0.2%
C71 Mozak M 314 0 7 7 11 3 8 11 10 10 16 26 39 58 34 39 35 2.3%
Brain 261 8 11 2 4 4 3 8 3 6 15 18 38 34 31 31 45 2.1%
C72 Centralni nervni sistem, drugi delovi M 12 0 0 4 1 1 0 0 2 0 1 1 0 1 1 0 0 0.1%
Spinal cord, cran. nerv. & oth. parts of CNS 2 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0.0%
C73 titasta lezda M 63 0 1 1 0 1 4 2 10 1 4 6 7 10 4 3 9 0.5%
Thyroid gland 161 0 0 0 2 5 3 13 10 13 17 17 26 23 8 13 11 1.3%
C74 Nadbubrena lezda M 11 1 0 0 0 0 0 0 0 1 0 0 4 1 2 2 0 0.1%
Adrenal gland 16 2 1 0 0 0 0 0 0 1 0 3 3 3 2 0 1 0.1%
C75 Endokrine lezde, druge M 10 0 0 0 2 0 0 0 0 1 1 1 0 1 1 1 2 0.1%
Other endocrine glands & related structures 5 0 0 0 1 0 0 0 0 0 0 1 1 0 0 0 2 0.0%
C76 Ostale lokalizacije M 48 0 0 1 0 0 0 1 1 0 2 1 10 9 7 5 11 0.3%
Other & ill defined sites 53 0 2 0 0 1 0 0 0 0 1 0 5 7 8 7 22 0.4%
C77-C80 Sekundarne lokalizacije, bez oznaene lokalizacije M 314 5 2 1 2 3 2 3 6 4 9 27 38 57 35 49 71 2.3%
Unspec.mal.neo. of lymph nod.& without of spec.of site 209 0 1 1 1 1 2 5 4 9 10 19 23 33 25 23 52 1.7%
C81 Hodgkinova bolest M 69 0 1 2 2 10 9 1 4 10 3 8 3 6 6 3 1 0.5%
Hodgkin's disease 56 0 0 1 5 7 3 10 4 3 1 3 3 4 1 7 4 0.5%
C82 Folikularni ne-Hodgkinov limfom M 40 0 0 0 0 0 0 0 1 3 1 8 4 9 2 4 8 0.3%
Follicular non-Hodgkin's lymphoma 62 0 0 0 0 1 1 6 1 4 10 5 5 10 10 5 4 0.5%
C83 Difuzni ne-Hodgkinov limfom M 113 1 0 0 1 0 2 5 2 5 2 18 15 10 6 20 26 0.8%
Diffuse non-Hodgkin's lymphoma 94 1 0 0 0 0 5 2 0 2 5 8 11 15 8 18 19 0.8%
C84 Periferni i koni limfom T-elija M 4 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 2 0.0%
Peripheral & cutaneous T-cell lymphomas 5 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 2 0.0%
C85 Ne-Hodgkinovi limfomi, drugi M 73 0 0 1 0 0 0 4 3 3 3 10 5 9 12 13 10 0.5%
Other & unspecified types of non-Hodgkin's lymphoma 61 0 0 1 0 0 0 1 2 0 1 5 9 5 5 15 17 0.5%
C88 Zloudne imunoproliferativne bolesti M 8 0 0 0 0 0 0 0 0 1 0 1 0 1 1 1 3 0.1%
Malignant immunoproliferative diseases 6 0 0 0 0 0 0 1 0 0 0 1 2 1 0 1 0 0.0%
C90 Multipli mijelom i drugi zloudni tumori plazma elija M 85 1 0 0 0 1 0 0 0 3 5 9 5 16 17 10 18 0.6%
Multiple myeloma and malignant plasma cell neoplasms 78 0 0 0 0 0 0 0 1 1 3 10 11 11 14 16 11 0.6%
C91 Limphoidna leukemija M 106 6 3 3 2 2 6 0 2 0 4 3 15 17 7 17 19 0.8%
Lymphoblastic, lymphoid leukaemia 76 5 5 0 1 0 0 0 0 3 3 5 4 5 10 12 23 0.6%
C92 Mijeloidna leukemija M 86 0 0 0 2 1 1 2 0 2 5 9 5 5 9 16 29 0.6%
Myeloid leukaemia 69 0 0 0 1 2 3 1 0 10 5 6 6 6 5 6 18 0.6%
C93 Monocitna leukemija M 3 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0.0%
Monocytic leukaemia 4 0 0 0 0 0 0 0 0 1 0 1 0 1 0 0 1 0.0%
C94 Leukemije, druge M 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.0%
Other leukaemias of specified cells 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0.0%
C95 Leukemije, neoznaene M 11 0 0 1 0 0 1 0 0 0 1 0 1 1 1 0 5 0.1%
Leukaemia, unspecified cell type 8 1 0 0 1 0 0 0 0 0 2 0 1 1 0 0 2 0.1%
C96 Drugi zloudni tumori hematopoeznog sistema M 3 1 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0.0%
Oth.&unspec.mal.neo. of lymph.,haematopoietic & related tissue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
C00-C96 Sve lokalizacije, bez koe M 12238 22 23 38 38 73 92 116 158 224 404 974 1697 2040 1691 1971 2677 88.3%
(C44) All sites but skin 10851 22 25 13 38 44 79 186 274 521 763 1151 1579 1636 1193 1299 2028 87.8%
Tabela 19. Incidencija od raka na 100.000 stanovnika prema primarnoj lokalizaciji (MKB-10), uzrastu i polu,
Table 19. Cancer incidence rates per 100.000 population by primary site (ICD-10), age and sex, Central Serbia, 2012
Sirovi Stand.
POL U Z R A S T (A g e )
mort. mort.
Primarna lokalizacija Primary site SEX CR 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ ASR
M (Male ) 539.2 17.6 17.4 29.6 27.3 46.1 54.7 71.3 92.5 143.2 263.7 577.0 883.1 1196.0 1615.1 1996.7 1889.9 289.5
(Female ) 456.6 18.6 19.9 10.4 27.5 28.9 49.4 114.3 161.0 312.2 456.7 637.4 771.9 869.7 1017.3 1092.2 1013.2 246.7
Usna M 3.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.5 0.6 1.2 3.3 4.8 9.0 10.1 8.0 9.9 1.6
Lip 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.4 2.2 2.8 4.0 0.3
Jezik, koren M 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 3.8 4.4 1.1 0.0 1.8 0.6 0.5
Base of tongue 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.5 0.7 0.7 0.0 0.1
Jezik, drugi delovi M 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.4 7.7 4.7 2.5 0.0 1.7 0.9
Tongue, other & unspecified parts 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.5 0.0 0.7 2.1 1.2 0.2
Desni M 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.5 0.0 0.0 0.6 0.1
Gum 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1
Pod usta M 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.7 1.2 5.5 3.9 5.8 3.4 1.8 4.7 1.1
Floor of mouth 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 1.0 0.0 1.9 1.4 1.4 0.8 0.3
Nepce M 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 1.6 1.0 2.1 1.7 0.9 0.6 0.4
Palate 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1
Usta, drugi delovi M 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 1.1 0.0 1.8 2.9 0.2
Mouth, other & unspecified parts 1.2 0.0 0.0 0.0 0.0 0.6 0.6 1.1 3.8 2.9 3.4 1.0 1.4 0.0 0.7 0.7 1.6 0.9
Parotidna lezda M 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.6 0.0 1.0 2.6 1.7 2.7 2.9 0.4
Parotid gland 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.5 0.9 1.0 0.7 2.8 0.8 0.3
Pljuvana lezda M 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.9 3.5 0.2
Other & unspec. major salivary gl. 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 1.4 0.0 0.7 0.7 1.6 0.2
Krajnik M 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 4.4 2.6 2.5 4.4 4.1 0.6
Tonsil 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 1.4 1.2 0.1
Orofarings M 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 3.3 4.4 4.7 5.9 0.0 0.6 0.9
Oropharynx 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 1.9 0.0 3.5 2.0 0.4
Nasofarings M 2.1 0.0 0.0 0.0 0.0 3.7 1.7 0.0 1.6 1.7 4.1 6.0 3.4 4.2 0.0 1.8 2.3 1.6
Nasopharynx 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 1.0 0.7 2.1 1.2 0.2
Piriformni sinus M 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.1
Pyriform sinus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Hipofarings M 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 6.0 9.7 7.4 13.4 2.7 3.5 1.7
Hypopharynx 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 1.4 0.5 0.0 0.7 0.0 0.2
Usne, usta, drelo, drugi delovi M 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 1.6 3.4 0.0 2.9 0.4
Other and ill def. sites in the lip, oral cavity & pharynx 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.5 0.0 0.7 0.7 1.6 0.2
Jednjak M 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.2 5.9 9.9 13.5 22.2 12.6 21.2 14.6 3.5
Oesophagus 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.0 0.9 0.5 2.9 4.2 2.0 0.5
eludac M 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 7.5 9.4 18.6 33.4 41.2 61.3 83.2 77.5 10.2
Stomach 9.4 0.0 0.0 0.0 0.0 0.0 0.6 1.7 1.1 1.7 3.4 9.9 12.3 13.8 28.0 35.7 29.7 4.2
Tanko crevo M 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 1.5 2.6 5.0 1.8 7.0 0.6
Small intestine 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.0 0.9 2.4 2.9 3.5 2.4 0.5
Debelo crevo M 38.4 0.0 0.0 0.0 0.0 1.8 1.1 0.5 1.6 8.1 14.1 42.7 60.4 84.4 147.9 166.4 123.6 19.9
Colon 22.4 0.0 0.0 0.0 0.0 0.6 1.7 2.8 4.4 9.7 18.2 24.0 32.7 50.0 56.0 64.4 57.8 10.9
Rektosigmoidni prelaz M 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 4.1 4.4 5.3 7.4 17.6 18.6 14.6 2.3
Rectosigmoid junction 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.7 4.2 4.1 8.1 10.1 12.6 9.5 1.6
Rektum M 24.2 0.0 0.0 0.0 0.0 0.0 0.6 2.7 3.8 8.1 10.6 20.8 45.9 49.1 79.0 86.7 93.3 12.4
Rectum 13.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 1.1 5.2 4.6 9.9 18.2 22.8 33.0 44.8 45.1 5.7
Anus i analni kanal M 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.2 0.0 1.9 1.6 1.7 2.7 2.9 0.4
Anus & anal canal 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.0 0.0 0.7 0.8 0.1
Jetra, uni kanali M 9.1 0.0 0.0 0.8 0.0 1.2 0.6 0.0 1.6 0.6 3.5 7.1 11.1 19.0 25.2 46.0 37.9 4.6
Liver & intrahepatic bile ducts 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.3 1.7 4.2 5.0 9.5 17.2 26.6 30.1 2.7
una kesa M 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.7 1.0 1.6 4.2 2.7 5.2 0.6
Gallbladder 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.5 3.2 4.8 7.2 10.5 10.7 1.1
uni kanali, drugi delovi M 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.7 1.7 1.8 2.9 0.3
Billiary tract, other & unspec. parts 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.0 0.9 3.3 2.9 2.1 3.6 0.6
Pankreas M 12.5 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.5 2.9 7.6 18.1 21.3 24.3 33.6 41.6 53.0 6.4
Pancreas 10.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 3.4 6.3 5.2 11.4 21.4 26.6 28.0 37.6 4.4
Organi za varenje, nedovoljno odredjene lokalizacije M 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 1.5 1.1 0.8 4.4 3.5 0.3
Other & ill-defined digestive organs 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.7 3.5 5.9 0.3
Nosna upljina i srednje uvo M 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.5 0.0 0.0 1.6 1.0 1.6 4.2 0.0 2.3 0.5
Nasal cavity & middle ear 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.5 2.9 0.7 1.6 0.2
Nosni sinusi M 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.9 1.1 1.7 3.5 0.6 0.5
Accessory sinuses 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.5 0.0 0.0 1.2 0.1
Larings M 17.8 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 7.0 21.7 22.5 45.9 45.9 61.3 50.4 31.5 10.1
Larynx 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.3 1.6 5.0 6.2 5.0 2.8 4.0 1.0
Traheja M 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.9 1.2 0.1
Trachea 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1
Bronh i plua M 121.3 0.0 0.0 0.0 0.0 0.0 1.7 3.3 5.4 21.5 66.4 172.6 288.1 347.1 390.8 395.6 272.2 65.0
Bronchus & lung 35.4 0.0 0.0 0.0 0.0 0.6 0.0 1.1 6.0 9.2 36.4 54.9 84.5 82.3 86.9 82.6 64.1 18.2
Timus M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Thymus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Srce, mediastinum, pleura M 1.7 0.0 0.0 0.0 0.0 1.2 0.0 1.1 0.0 1.2 2.3 1.6 4.4 3.2 3.4 7.1 2.3 1.0
Heart, mediastinum & pleura 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.5 1.0 2.9 2.8 1.2 0.3
Toraks, druge lokalizacije M 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0
Other & ill-def. in the res.sys. 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0
Kosti i zglobne hrskavice udova M 2.1 0.0 5.3 9.1 4.0 2.5 0.6 0.5 1.1 1.7 0.6 1.1 1.5 2.1 0.8 2.7 1.7 2.5
Bone & articular cartilage of limbs 1.6 0.0 2.4 4.8 9.2 0.6 1.2 0.6 1.1 0.0 1.7 0.5 0.5 1.9 0.0 2.8 0.8 2.0
Kosti i zglobne hrskavice, druge lokalizacije M 1.2 0.8 1.5 0.0 0.7 1.2 0.6 0.0 0.0 1.2 0.6 2.2 2.4 2.6 0.0 3.5 2.3 1.0
Bone & articular cartilage of other 1.2 0.8 0.0 0.0 2.1 0.0 0.6 0.6 0.0 0.6 0.6 1.0 0.5 3.3 1.4 3.5 2.8 0.8
Koa, maligni melanom M 9.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 3.3 5.8 7.0 7.1 21.3 15.3 26.9 33.6 28.6 5.1
Malignant melanoma of skin 8.1 0.0 0.0 0.0 1.4 0.6 1.7 3.9 3.8 12.0 9.7 8.9 12.3 7.6 20.1 18.2 19.0 4.7
Koa, drugi maligni tumori M 63.1 0.0 0.0 0.8 2.0 1.2 2.8 7.7 6.5 13.3 26.4 43.3 62.8 119.8 194.1 252.2 329.4 30.7
Skin, other malignomas 55.7 0.0 0.0 0.0 0.7 0.6 3.5 10.1 11.5 13.7 22.2 36.1 54.5 91.3 160.2 182.7 210.6 24.2
Mezoteliom M 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.8 1.8 1.2 0.2
Mesothelioma 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0
Kaposijev sarkom M 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0
Kaposi's sarcoma 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.2
Periferni nervi i autonomni nervni sistem M 0.4 1.6 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.8 0.9 0.6 0.4
Peripheral nerves & auton. nerv. sys. 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.7 1.4 0.4 0.2
Peritoneum i retroperitoneum M 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.6 0.0 1.1 1.0 2.6 1.7 2.7 3.5 0.6
Retroperitoneum & peritoneum 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 1.7 4.7 2.7 2.4 0.7 2.1 2.0 0.7
Vezivna i meka tkiva, drugi M 2.5 0.0 0.0 0.0 0.7 3.7 0.6 3.3 3.3 1.7 3.5 3.3 3.9 5.8 1.7 3.5 2.9 1.8
Other connective and soft tissue 3.3 0.8 0.0 0.8 0.0 0.6 0.6 1.7 2.2 4.6 2.3 7.8 9.1 2.4 3.6 4.9 5.1 2.1
Dojka M 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.6 0.6 1.6 4.8 4.2 8.4 9.7 7.0 1.3
Breast 117.7 0.0 0.0 0.0 0.7 1.9 11.0 25.8 55.1 115.2 176.0 220.0 235.8 238.4 249.3 199.5 171.4 68.3
Tabela 19.1 Incidencija od raka na 100.000 stanovnika prema primarnoj lokalizaciji (MKB010), uzrastu i polu,
centralna Srbija, 2012. godina (nastavak)
Table 19.1 Cancer incidence rates per 100.000 population by primary site (ICD010), age and sex, Central Serbia, 2012 (continued)
Sirovi Stand.
POL U Z R A S T (A g e )
mort. mort.
Primarna lokalizacija Primary site SEX CR 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ ASR
M (Male ) 539.2 17.6 17.4 29.6 27.3 46.1 54.7 71.3 92.5 143.2 263.7 577.0 883.1 1196.0 1615.1 1996.7 1889.9 289.5
(Female ) 456.6 18.6 19.9 10.4 27.5 28.9 49.4 114.3 161.0 312.2 456.7 637.4 771.9 869.7 1017.3 1092.2 1013.2 246.7
Vulva 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.1 0.6 1.0 2.3 4.3 4.3 9.8 15.0 1.1
Vulva
Vagina 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.5 1.8 1.4 2.9 2.1 2.4 0.5
Vagina
Grli materice 36.4 0.0 0.0 0.0 0.0 1.3 6.4 24.1 29.5 57.3 58.1 79.4 67.2 60.9 49.6 53.2 40.0 23.2
Cervix uteri
Materica, telo 26.7 0.0 0.0 0.8 0.0 0.6 0.6 3.9 5.5 10.3 17.1 44.4 68.6 61.8 63.2 63.0 43.5 13.8
Corpus uteri
Materica, neoznaeni deo 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.1 1.6 0.0 3.3 0.7 2.1 1.6 0.4
Jajnik 16.7 0.0 0.8 0.0 0.7 5.1 5.2 4.5 14.2 16.6 19.9 25.6 23.6 35.2 35.2 34.3 24.9 10.2
Ovary
enski genitalni organi, drugi neoznaeni organi 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 1.1 0.0 0.9 1.9 0.0 2.1 2.8 0.3
Placenta 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Placenta
Penis M 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.6 0.6 2.2 2.4 5.3 3.4 2.7 8.2 0.9
Penis
Prostata M 68.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 17.5 52.2 112.4 219.3 393.8 401.1 30.0
Prostate
Testis M 7.6 0.0 0.0 0.8 3.3 14.7 23.1 22.5 17.4 11.0 4.1 6.0 3.4 2.1 1.7 1.8 0.0 7.3
Testis
Muki genitalni organi, drugi neoznaeni organi M 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.8 0.0 0.6 0.1
Bubreg M 11.4 2.4 0.0 0.0 0.7 0.0 0.0 2.2 3.8 5.2 6.5 17.5 21.3 32.2 27.7 38.9 25.6 6.5
Kidney, except renal pelvis 6.2 0.0 0.8 0.0 0.7 1.3 1.2 1.1 2.2 3.4 5.7 5.7 11.8 10.5 7.9 20.3 16.2 3.2
Bubrena karlica M 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 1.9 3.7 0.8 4.4 2.3 0.5
Renal pelvis 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.5 0.5 1.0 2.2 0.0 0.8 0.2
Ureter M 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 1.1 3.4 2.7 0.6 0.3
Ureter 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.7 2.1 2.0 0.2
Mokrana beika M 30.2 0.0 0.0 0.0 0.0 0.0 1.1 1.6 3.8 7.5 14.1 31.8 40.1 63.3 92.4 108.9 135.2 15.1
Bladder 9.7 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 1.7 4.0 14.6 12.3 22.8 19.4 27.3 31.7 4.4
Urinarni organi, drugi neoznaeni organi M 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1
Other & unspecified urinary organs 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 2.8 0.4 0.1
Oko, pripoji oka M 1.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 1.1 1.0 3.7 1.7 3.5 2.9 0.6
Eye and adnexa 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 1.0 1.4 2.9 2.2 3.5 2.8 0.6
Modanice M 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 1.1 1.0 0.5 2.5 3.5 1.7 0.4
Meninges 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 0.0 2.3 1.4 2.9 1.4 1.6 0.4
Mozak M 12.2 0.0 5.3 5.3 7.3 1.8 4.5 6.0 5.4 5.8 9.4 14.2 18.9 30.6 28.6 34.5 20.4 8.4
Brain 9.6 6.8 8.8 1.6 2.8 2.6 1.7 4.5 1.6 3.4 8.5 9.4 17.3 16.2 22.3 21.7 17.8 6.8
Centralni nervni sistem, drugi delovi M 0.5 0.0 0.0 3.0 0.7 0.6 0.0 0.0 1.1 0.0 0.6 0.5 0.0 0.5 0.8 0.0 0.0 0.6
Spinal cord, cran. nerv. & oth. parts of CNS 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1
titasta lezda M 2.5 0.0 0.8 0.8 0.0 0.6 2.3 1.1 5.4 0.6 2.3 3.3 3.4 5.3 3.4 2.7 5.2 1.7
Thyroid gland 5.9 0.0 0.0 0.0 1.4 3.2 1.7 7.3 5.5 7.4 9.7 8.9 11.8 10.9 5.7 9.1 4.4 4.1
Nadbubrena lezda M 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.9 0.5 1.7 1.8 0.0 0.3
Adrenal gland 0.6 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 1.4 1.4 1.4 0.0 0.4 0.6
Endokrine lezde, druge M 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.6 0.5 0.0 0.5 0.8 0.9 1.2 0.3
Other endocrine glands & related structures 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.8 0.1
Ostale lokalizacije M 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.5 0.0 1.2 0.5 4.8 4.7 5.9 4.4 6.4 1.0
Other & ill defined sites 2.0 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 2.3 3.3 5.7 4.9 8.7 0.9
Sekundarne lokalizacije, bez oznaene lokalizacije M 12.2 4.0 1.5 0.8 1.3 1.8 1.1 1.6 3.3 2.3 5.3 14.8 18.4 30.1 29.4 43.4 41.4 7.1
Unspec.mal.neo. of lymph nod.& without of spec.of site 7.7 0.0 0.8 0.8 0.7 0.6 1.2 2.8 2.2 5.2 5.7 9.9 10.4 15.7 18.0 16.1 20.6 4.1
Hodgkinova bolest M 2.7 0.0 0.8 1.5 1.3 6.1 5.1 0.5 2.2 5.8 1.8 4.4 1.5 3.2 5.0 2.7 0.6 2.5
Hodgkin's disease 2.1 0.0 0.0 0.8 3.5 4.5 1.7 5.6 2.2 1.7 0.6 1.6 1.4 1.9 0.7 4.9 1.6 1.9
Folikularni ne-Hodgkinov limfom M 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.6 4.4 1.9 4.7 1.7 3.5 4.7 0.9
Follicular non-Hodgkin's lymphoma 2.3 0.0 0.0 0.0 0.0 0.6 0.6 3.4 0.5 2.3 5.7 2.6 2.3 4.8 7.2 3.5 1.6 1.5
Difuzni ne-Hodgkinov limfom M 4.4 0.8 0.0 0.0 0.7 0.0 1.1 2.7 1.1 2.9 1.2 9.9 7.3 5.3 5.0 17.7 15.2 2.5
Diffuse non-Hodgkin's lymphoma 3.5 0.8 0.0 0.0 0.0 0.0 2.9 1.1 0.0 1.1 2.8 4.2 5.0 7.1 5.7 12.6 7.5 1.9
Periferni i koni limfom T-elija M 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.1
Peripheral & cutaneous T-cell lymphomas 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.8 0.1
Ne-Hodgkinovi limfomi, drugi M 2.8 0.0 0.0 0.8 0.0 0.0 0.0 2.2 1.6 1.7 1.8 5.5 2.4 4.7 10.1 11.5 5.8 1.7
Other & unspecified types of non-Hodgkin's lymphoma 2.3 0.0 0.0 0.8 0.0 0.0 0.0 0.6 1.1 0.0 0.6 2.6 4.1 2.4 3.6 10.5 6.7 1.0
Zloudne imunoproliferativne bolesti M 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.5 0.8 0.9 1.7 0.2
Malignant immunoproliferative diseases 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.9 0.5 0.0 0.7 0.0 0.1
Multipli mijelom i drugi zloudni tumori plazma elija M 3.3 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 2.9 4.9 2.4 8.4 14.3 8.9 10.5 1.9
Multiple myeloma and malignant plasma cell neoplasms 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.7 5.2 5.0 5.2 10.1 11.2 4.4 1.5
Limphoidna leukemija M 4.1 4.8 2.3 2.3 1.3 1.2 3.4 0.0 1.1 0.0 2.3 1.6 7.3 9.0 5.9 15.0 11.1 3.1
Lymphoblastic, lymphoid leukaemia 2.8 4.2 4.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 1.7 2.6 1.8 2.4 7.2 8.4 9.1 2.0
Mijeloidna leukemija M 3.3 0.0 0.0 0.0 1.3 0.6 0.6 1.1 0.0 1.2 2.9 4.9 2.4 2.6 7.6 14.2 16.9 1.8
Myeloid leukaemia 2.5 0.0 0.0 0.0 0.7 1.3 1.7 0.6 0.0 5.7 2.8 3.1 2.7 2.9 3.6 4.2 7.1 1.6
Monocitna leukemija M 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.1
Monocytic leukaemia 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.5 0.0 0.0 0.4 0.1
Leukemije, druge M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0
Other leukaemias of specified cells 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0
Leukemije, neoznaene M 0.4 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.8 0.0 2.9 0.3
Leukaemia, unspecified cell type 0.3 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.5 0.0 0.0 0.8 0.3
Drugi zloudni tumori hematopoeznog sistema M 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.1
Oth.&unspec.mal.neo. of lymph.,haematopoietic & related tissue 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sve lokalizacije, bez koe M 476.1 17.6 17.4 28.8 25.3 44.9 51.9 63.6 85.9 129.9 237.3 533.7 820.3 1076.3 1421.0 1744.4 1560.5 258.7
All sites but skin 400.9 18.6 19.9 10.4 26.8 28.2 45.9 104.2 149.5 298.5 434.5 601.4 717.4 778.3 857.1 909.5 802.6 222.6
Tabela 20. Broj umrlih sluajeva od raka, prema primarnoj lokalizaciji (MKB-10), uzrastu i polu,
Table 20. Number of cancer deaths by primary site (ICD-10), age and sex, Central Serbia, 2012
MKB-10 POL Ukupno U Z R A S T (A g e )

(ICD-10 ) SEX (All ) 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ %
Primarna lokalizacija Primary site
ifra (Code ) M (Male ) 8694 7 2 5 7 7 25 23 49 92 196 501 1033 1367 1157 1399 2824 100.0%
Ukupno (All ) ( Female ) 6537 4 4 2 7 2 9 30 65 126 220 423 720 889 719 1011 2306 100.0%
C00 Usna M 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0.1%
Lip 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 9 0.2%
C01 Jezik, koren M 22 0 0 0 0 0 0 1 0 1 0 1 8 4 3 1 3 0.3%
Base of tongue 4 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 1 0.1%
C02 Jezik, drugi delovi M 35 0 0 0 0 0 0 0 2 1 1 5 8 10 4 2 2 0.4%
Tongue, other & unspecified parts 8 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 6 0.1%
C03 Desni M 3 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0.0%
Gum 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0.0%
C04 Pod usta M 27 0 0 0 0 0 0 1 0 0 2 6 5 6 3 2 2 0.3%
Floor of mouth 7 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 3 0.1%
C05 Nepce M 3 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0.0%
Palate 3 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0.0%
C06 Usta, drugi delovi M 7 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 3 0.1%
Mouth, other & unspecified parts 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0.0%
C07 Parotidna lezda M 12 0 0 0 0 0 0 0 0 0 1 0 1 3 1 1 5 0.1%
Parotid gland 4 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0.1%
C08 Pljuvana lezda M 5 0 0 0 0 0 0 0 0 1 0 0 1 0 2 1 0 0.1%
Other & unspec. major salivary gl. 5 0 0 0 0 0 0 0 1 0 0 0 1 0 1 1 1 0.1%
C09 Krajnik M 20 0 0 0 0 0 0 0 0 2 0 2 3 4 1 3 5 0.2%
Tonsil 4 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 2 0.1%
C10 Orofarings M 25 0 0 0 0 0 0 0 0 0 1 4 7 6 3 1 3 0.3%
Oropharynx 6 0 0 0 0 0 0 0 0 0 0 1 2 0 1 1 1 0.1%
C11 Nasofarings M 20 0 0 0 0 0 0 0 1 2 1 1 1 5 1 2 6 0.2%
Nasopharynx 10 0 0 0 0 0 0 0 0 0 0 0 1 2 1 3 3 0.2%
C12 Piriformni sinus M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
Pyriform sinus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
C13 Hipofarings M 53 0 0 0 0 0 0 0 0 1 4 4 9 13 8 7 7 0.6%
Hypopharynx 9 0 0 0 0 0 0 1 0 0 0 2 2 2 0 1 1 0.1%
C14 Usne, usta, drelo, drugi delovi M 11 0 0 0 0 0 0 0 0 0 2 1 0 0 4 2 2 0.1%
Other and ill def. sites in the lip, oral cavity & pharynx 5 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 2 0.1%
C15 Jednjak M 160 0 0 0 0 0 0 0 0 4 5 15 36 23 20 27 30 1.8%
Oesophagus 31 0 0 0 0 0 0 0 0 0 1 2 6 4 3 6 9 0.5%
C16 eludac M 497 0 0 0 0 0 1 1 4 4 12 28 63 79 48 99 158 5.7%
Stomach 311 0 0 0 0 0 0 2 3 2 5 21 23 38 21 57 139 4.8%
C17 Tanko crevo M 17 0 0 0 0 0 0 0 0 1 0 1 1 2 0 2 10 0.2%
Small intestine 11 0 0 0 0 0 0 0 0 0 0 1 0 2 1 2 5 0.2%
C18 Debelo crevo M 569 0 0 0 1 0 0 2 2 4 4 20 45 75 85 101 230 6.5%
Colon 379 0 0 0 0 0 0 2 4 7 10 12 24 35 40 72 173 5.8%
C19 Rektosigmoidni prelaz M 67 0 0 0 0 0 0 0 0 0 1 6 4 9 7 9 31 0.8%
Rectosigmoid junction 47 0 0 0 0 0 0 0 1 0 1 1 4 9 3 7 21 0.7%
C20 Rektum M 498 0 0 0 0 0 2 2 0 6 7 18 40 61 63 102 197 5.7%
Rectum 306 0 0 0 0 0 1 1 1 3 4 17 29 36 27 49 138 4.7%
C21 Anus i analni kanal M 9 0 0 0 0 0 0 0 0 1 0 0 0 1 1 3 3 0.1%
Anus & anal canal 10 0 0 0 0 0 0 0 0 0 0 1 0 3 3 1 2 0.2%
C22 Jetra, uni kanali M 283 0 0 0 0 0 1 1 2 0 3 10 26 38 44 60 98 3.3%
Liver & intrahepatic bile ducts 233 0 0 0 0 0 0 0 0 0 7 12 16 28 23 39 108 3.6%
C23 una kesa M 40 0 0 0 0 0 0 0 0 0 0 4 3 6 3 5 19 0.5%
Gallbladder 109 0 0 0 0 0 0 0 0 1 1 4 7 11 12 20 53 1.7%
C24 uni kanali, drugi delovi M 56 0 0 0 0 0 0 0 0 0 1 0 4 12 7 12 20 0.6%
Billiary tract, other & unspec. parts 39 0 0 0 0 0 0 0 0 0 1 2 2 3 8 6 17 0.6%
C25 Pankreas M 441 0 0 0 0 0 0 1 2 6 9 29 50 56 54 70 164 5.1%
Pancreas 386 0 0 0 0 0 0 1 0 4 3 9 34 50 48 74 163 5.9%
C26 Organi za varenje, nedovoljno odredjene lokalizacije M 23 0 0 0 0 0 0 0 0 0 0 0 4 2 2 4 11 0.3%
Other & ill-defined digestive organs 33 0 0 0 0 0 0 0 1 0 0 0 1 6 3 7 15 0.5%
C30 Nosna upljina i srednje uvo M 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0.0%
Nasal cavity & middle ear 6 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 4 0.1%
C31 Nosni sinusi M 9 0 0 0 0 0 0 0 0 0 0 2 3 1 0 0 3 0.1%
Accessory sinuses 6 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 4 0.1%
C32 Larings M 276 0 0 0 0 0 0 1 0 2 13 14 50 53 43 40 60 3.2%
Larynx 37 0 0 0 0 0 0 0 0 2 1 3 7 5 0 6 13 0.6%
C33 Traheja M 7 0 0 0 0 0 0 0 0 0 0 0 1 3 0 1 2 0.1%
Trachea 6 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 3 0.1%
C34 Bronh i plua M 2588 0 0 0 0 0 2 0 5 18 68 197 415 537 413 384 549 29.8%
Bronchus & lung 963 0 0 0 0 0 1 0 4 17 42 81 159 190 125 136 208 14.7%
C37 Timus M 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0.0%
Thymus 5 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 3 0.1%
C38 Srce, mediastinum, pleura M 33 0 0 0 0 0 0 0 1 1 3 1 4 5 6 3 9 0.4%
Heart, mediastinum & pleura 20 0 0 0 0 0 0 0 0 2 1 0 0 3 2 1 11 0.3%
C39 Toraks, druge lokalizacije M 3 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 1 0.0%
Other & ill-def. in the res.sys. 5 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 2 0.1%
C40 Kosti i zglobne hrskavice udova M 8 0 0 2 0 1 1 0 0 0 0 1 0 1 0 1 1 0.1%
Bone & articular cartilage of limbs 6 0 0 0 1 0 1 0 0 0 0 0 0 0 2 0 2 0.1%
C41 Kosti i zglobne hrskavice, druge lokalizacije M 29 0 0 0 1 0 2 0 0 1 0 2 3 2 4 4 10 0.3%
Bone & articular cartilage of other 9 0 0 0 0 0 0 0 0 0 1 0 0 1 1 1 5 0.1%
C43 Koa, maligni melanom M 107 0 0 0 0 0 2 3 3 3 4 10 14 11 12 13 32 1.2%
Malignant melanoma of skin 83 0 0 0 0 0 1 0 1 3 3 10 11 7 17 8 22 1.3%
C44 Koa, drugi maligni tumori M 69 0 0 0 0 0 0 0 0 0 0 2 6 7 5 9 40 0.8%
Skin, other malignomas 63 0 0 0 0 0 1 0 0 0 0 1 4 4 2 13 38 1.0%
C45 Mezoteliom M 22 0 0 0 0 0 0 0 0 0 2 1 2 2 5 5 5 0.3%
Mesothelioma 7 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 2 0.1%
C46 Kaposijev sarkom M 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0.0%
Kaposi's sarcoma 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
C47 Periferni nervi i autonomni nervni sistem M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
Peripheral nerves & auton. nerv. sys. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
C48 Peritoneum i retroperitoneum M 17 0 0 0 0 0 0 1 0 0 0 2 2 4 1 2 5 0.2%
Retroperitoneum & peritoneum 35 0 0 1 0 0 0 0 2 0 0 0 2 6 4 8 12 0.5%
C49 Vezivna i meka tkiva, drugi M 10 0 0 0 0 0 1 0 0 1 0 1 1 2 0 0 4 0.1%
Other connective and soft tissue 20 1 0 0 1 1 0 1 0 2 0 2 0 4 1 2 5 0.3%
C50 Dojka M 19 0 0 0 0 0 0 0 0 0 0 0 4 4 2 1 8 0.2%
Breast 1175 0 0 0 0 0 1 7 15 34 62 92 158 161 137 140 368 18.0%
Tabela 20.1 Broj umrlih sluajeva od raka, prema primarnoj lokalizaciji (MKB-10), uzrastu i polu,
Table 20.1 Number of cancer deaths by primary site (ICD-10), age and sex, Central Serbia, 2012 (continued)
MKB-10 POL Ukupno U Z R A S T (A g e)

(ICD-10 ) SEX (All) 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ %
Primarna lokalizacija Primary site
ifra (Code ) M (Male ) 8694 7 2 5 7 7 25 23 49 92 196 501 1033 1367 1157 1399 2824 100.0%
Ukupno (All ) (Female ) 6537 4 4 2 7 2 9 30 65 126 220 423 720 889 719 1011 2306 100.0%
C51 Vulva 51 0 0 0 0 0 0 0 1 2 0 1 4 1 2 9 31 0.8%
Vulva
C52 Vagina 9 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 6 0.1%
Vagina
C53 Grli materice 334 0 0 0 0 0 0 4 12 16 24 38 46 35 31 51 77 5.1%
Cervix uteri
C54 Materica, telo 174 0 0 0 0 0 0 0 2 1 7 15 12 28 22 29 58 2.7%
Corpus uteri
C55 Materica, neoznaeni deo 53 0 0 0 0 0 0 0 1 2 4 1 4 6 3 11 21 0.8%
C56 Jajnik 294 0 0 0 0 0 0 2 2 11 13 22 42 56 37 42 67 4.5%
Ovary
C57 enski genitalni organi, drugi neoznaeni organi 23 0 0 0 0 0 0 0 0 0 0 0 3 3 1 6 10 0.4%
C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
Placenta
C60 Penis M 18 0 0 0 0 0 0 0 0 1 1 0 1 2 0 1 12 0.2%
Penis
C61 Prostata M 758 0 0 0 0 0 0 0 0 0 1 4 23 56 68 137 469 8.7%
Prostate
C62 Testis M 18 0 0 0 0 1 2 0 3 5 0 1 3 1 0 1 1 0.2%
Testis
C63 Muki genitalni organi, drugi neoznaeni organi M 8 0 0 0 0 0 0 0 0 0 0 1 1 1 2 0 3 0.1%
C64 Bubreg M 167 0 0 0 0 0 0 0 0 3 3 13 19 32 24 28 45 1.9%
Kidney, except renal pelvis 95 0 1 0 0 0 0 0 1 1 1 2 7 5 15 21 41 1.5%
C65 Bubrena karlica M 8 0 0 0 0 0 0 0 0 0 1 0 0 1 0 2 4 0.1%
Renal pelvis 6 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 3 0.1%
C66 Ureter M 5 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 3 0.1%
Ureter 6 0 0 0 0 0 0 0 0 0 0 1 1 0 0 2 2 0.1%
C67 Mokrana beika M 418 0 0 0 0 0 0 0 1 2 7 18 26 43 55 57 209 4.8%
Bladder 106 0 0 0 0 0 0 0 0 1 2 3 6 11 10 17 56 1.6%
C68 Urinarni organi, drugi neoznaeni organi M 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0.0%
Other & unspecified urinary organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0%
C69 Oko, pripoji oka M 11 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 9 0.1%
Eye and adnexa 10 0 0 0 0 0 0 0 0 0 0 0 0 0 1 5 4 0.2%
C70 Modanice M 11 0 0 0 0 0 0 0 0 0 2 0 1 1 3 3 1 0.1%
Meninges 12 0 0 0 0 0 0 0 0 0 0 0 2 1 1 2 6 0.2%
C71 Mozak M 273 4 0 2 1 1 4 2 11 8 15 17 33 57 34 45 39 3.1%
Brain 221 2 2 0 1 1 1 4 4 6 11 14 32 30 29 27 57 3.4%
C72 Centralni nervni sistem, drugi delovi M 4 0 0 0 1 0 1 0 1 0 0 0 0 0 0 1 0 0.0%
Spinal cord, cran. nerv. & oth. parts of CNS 3 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0.0%
C73 titasta lezda M 19 0 0 0 0 0 0 1 0 0 1 3 2 0 2 6 4 0.2%
Thyroid gland 24 0 0 0 0 0 0 0 0 0 0 5 1 6 0 6 6 0.4%
C74 Nadbubrena lezda M 13 0 0 0 0 0 0 0 0 0 0 1 2 2 2 2 4 0.1%
Adrenal gland 8 0 0 0 0 0 0 0 0 0 0 1 0 2 2 1 2 0.1%
C75 Endokrine lezde, druge M 9 0 0 0 0 0 0 1 0 0 0 1 0 3 1 1 2 0.1%
Other endocrine glands & related structures 3 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0.0%
C76 Ostale lokalizacije M 39 0 0 0 0 0 0 0 0 0 1 2 5 8 3 7 13 0.4%
Other & ill defined sites 85 0 0 0 0 0 0 0 0 1 3 5 5 12 7 8 44 1.3%
C77-C80 Sekundarne lokalizacije, bez oznaene lokalizacije M 315 0 0 0 0 0 0 0 3 3 5 16 42 53 36 51 106 3.6%
Unspec.mal.neo. of lymph nod.& without of spec.of site 260 0 0 0 0 0 0 1 2 4 4 12 24 29 26 42 116 4.0%
C81 Hodgkinova bolest M 28 0 0 0 0 1 1 1 2 1 3 1 3 3 6 1 5 0.3%
Hodgkin's disease 17 0 0 0 0 0 0 1 3 0 1 0 0 1 1 2 8 0.3%
C82 Folikularni ne-Hodgkinov limfom M 20 0 0 0 1 0 0 0 0 2 0 1 2 2 5 0 7 0.2%
Follicular non-Hodgkin's lymphoma 20 0 0 0 0 0 0 0 0 0 1 1 2 1 1 3 11 0.3%
C83 Difuzni ne-Hodgkinov limfom M 76 0 0 0 2 0 1 1 1 1 3 4 11 11 11 14 16 0.9%
Diffuse non-Hodgkin's lymphoma 34 0 0 0 0 0 0 0 0 0 0 1 4 6 5 7 11 0.5%
C84 Periferni i koni limfom T-elija M 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0.0%
Peripheral & cutaneous T-cell lymphomas 2 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0.0%
C85 Ne-Hodgkinovi limfomi, drugi M 38 0 0 0 0 0 0 1 0 0 1 5 2 2 5 7 15 0.4%
Other & unspecified types of non-Hodgkin's lymphoma 38 0 0 0 0 0 0 0 0 0 1 3 6 5 1 9 13 0.6%
C88 Zloudne imunoproliferativne bolesti M 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0.0%
Malignant immunoproliferative diseases 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0.0%
C90 Multipli mijelom i drugi zloudni tumori plazma elija M 75 0 0 0 0 0 0 0 0 1 2 9 7 13 9 13 21 0.9%
Multiple myeloma and malignant plasma cell neoplasms 49 0 0 0 0 0 0 0 1 0 2 4 5 10 8 13 6 0.7%
C91 Limphoidna leukemija M 104 0 1 1 0 1 1 1 1 2 3 6 10 10 16 15 36 1.2%
Lymphoblastic, lymphoid leukaemia 73 1 1 1 0 0 0 1 0 0 1 4 8 5 10 8 33 1.1%
C92 Mijeloidna leukemija M 105 2 1 0 0 2 2 1 3 2 2 5 9 11 13 16 36 1.2%
Myeloid leukaemia 86 0 0 0 2 0 2 1 2 4 1 11 5 9 8 11 30 1.3%
C93 Monocitna leukemija M 7 0 0 0 0 0 1 0 0 0 0 1 1 1 0 2 1 0.1%
Monocytic leukaemia 5 0 0 0 0 0 0 0 0 0 0 0 3 1 0 0 1 0.1%
C94 Leukemije, druge M 5 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0.1%
Other leukaemias of specified cells 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0.0%
C95 Leukemije, neoznaene M 11 0 0 0 0 0 0 0 0 0 0 1 1 0 2 3 4 0.1%
Leukaemia, unspecified cell type 8 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 5 0.1%
C96 Drugi zloudni tumori hematopoeznog sistema M 11 1 0 0 0 0 0 0 0 1 1 0 1 0 0 3 4 0.1%
Oth.&unspec.mal.neo. of lymph.,haematopoietic & related tissue 5 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 0.1%
C00-C96 Sve lokalizacije, bez koe M 8625 7 2 5 7 7 25 23 49 92 196 499 1027 1360 1152 1390 2784 99.2%
(C44) All sites but skin 6474 4 4 2 7 2 8 30 65 126 220 422 716 885 717 998 2268 99.0%
Tabela 21. Mortalitet od raka na 100.000 stanovnika prema primarnoj lokalizaciji (MKB-10), uzrastu i polu,
Table 21. Cancer mortality rates per 100.000 population by primary site (ICD-10), age and sex, Central Serbia, 2012
Sirovi Stand.
MKB-10 POL U Z R A S T (A g e )
mort. mort.
(ICD-10 ) Primarna lokalizacija Primary site SEX CR 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ ASR
ifra (Code ) M (Male ) 338.2 5.6 1.5 3.8 4.7 4.3 14.1 12.6 26.7 53.3 115.1 274.5 499.3 721.2 972.3 1238.2 1646.2 164.9
Ukupno (All ) (Female ) 241.5 3.4 3.2 1.6 4.9 1.3 5.2 16.8 35.5 72.2 125.3 221.0 327.1 423.0 516.6 707.8 912.7 105.8
C00 Usna M 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1
Lip 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.6 0.1
C01 Jezik, koren M 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.5 3.9 2.1 2.5 0.9 1.7 0.5
Base of tongue 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.7 0.4 0.1
C02 Jezik, drugi delovi M 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.6 2.7 3.9 5.3 3.4 1.8 1.2 0.8
Tongue, other & unspecified parts 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 2.4 0.1
C03 Desni M 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.1
Gum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0
C04 Pod usta M 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 3.3 2.4 3.2 2.5 1.8 1.2 0.6
Floor of mouth 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.4 1.2 0.1
C05 Nepce M 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.8 0.0 0.0 0.1
Palate 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.4 0.0
C06 Usta, drugi delovi M 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.5 0.0 0.0 1.7 0.1
Mouth, other & unspecified parts 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0
C07 Parotidna lezda M 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 1.6 0.8 0.9 2.9 0.2
Parotid gland 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.4 0.1
C08 Pljuvana lezda M 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 1.7 0.9 0.0 0.1
Other & unspec. major salivary gl. 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.7 0.7 0.4 0.1
C09 Krajnik M 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.1 1.5 2.1 0.8 2.7 2.9 0.4
Tonsil 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.8 0.1
C10 Orofarings M 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.2 3.4 3.2 2.5 0.9 1.7 0.5
Oropharynx 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.7 0.7 0.4 0.1
C11 Nasofarings M 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.6 0.5 0.5 2.6 0.8 1.8 3.5 0.4
Nasopharynx 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.7 2.1 1.2 0.1
C12 Piriformni sinus M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Pyriform sinus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
C13 Hipofarings M 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 2.2 4.4 6.9 6.7 6.2 4.1 1.1
Hypopharynx 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.9 1.0 0.0 0.7 0.4 0.2
C14 Usne, usta, drelo, drugi delovi M 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 3.4 1.8 1.2 0.3
Other and ill def. sites in the lip, oral cavity & pharynx 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.7 0.8 0.1
C15 Jednjak M 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.9 8.2 17.4 12.1 16.8 23.9 17.5 3.2
Oesophagus 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 2.7 1.9 2.2 4.2 3.6 0.5
C16 eludac M 19.3 0.0 0.0 0.0 0.0 0.0 0.6 0.5 2.2 2.3 7.0 15.3 30.5 41.7 40.3 87.6 92.1 9.2
Stomach 11.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.6 1.1 2.8 11.0 10.4 18.1 15.1 39.9 55.0 4.4
C17 Tanko crevo M 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.5 1.1 0.0 1.8 5.8 0.3
Small intestine 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.7 1.4 2.0 0.2
C18 Debelo crevo M 22.1 0.0 0.0 0.0 0.7 0.0 0.0 1.1 1.1 2.3 2.3 11.0 21.8 39.6 71.4 89.4 134.1 10.1
Colon 14.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.2 4.0 5.7 6.3 10.9 16.7 28.7 50.4 68.5 5.4
C19 Rektosigmoidni prelaz M 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 1.9 4.7 5.9 8.0 18.1 1.2
Rectosigmoid junction 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.5 1.8 4.3 2.2 4.9 8.3 0.7
C20 Rektum M 19.4 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 3.5 4.1 9.9 19.3 32.2 52.9 90.3 114.8 8.9
Rectum 11.3 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.5 1.7 2.3 8.9 13.2 17.1 19.4 34.3 54.6 4.4
C21 Anus i analni kanal M 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.8 2.7 1.7 0.2
Anus & anal canal 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 2.2 0.7 0.8 0.2
C22 Jetra, uni kanali M 11.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 1.1 0.0 1.8 5.5 12.6 20.0 37.0 53.1 57.1 5.1
Liver & intrahepatic bile ducts 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 6.3 7.3 13.3 16.5 27.3 42.7 3.3
C23 una kesa M 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.5 3.2 2.5 4.4 11.1 0.7
Gallbladder 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 2.1 3.2 5.2 8.6 14.0 21.0 1.5
C24 uni kanali, drugi delovi M 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.9 6.3 5.9 10.6 11.7 1.0
Billiary tract, other & unspec. parts 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.9 1.4 5.7 4.2 6.7 0.6
C25 Pankreas M 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 3.5 5.3 15.9 24.2 29.5 45.4 62.0 95.6 8.1
Pancreas 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.3 1.7 4.7 15.4 23.8 34.5 51.8 64.5 5.4
C26 Organi za varenje, nedovoljno odredjene lokalizacije M 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.1 1.7 3.5 6.4 0.4
Other & ill-defined digestive organs 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 2.9 2.2 4.9 5.9 0.4
C30 Nosna upljina i srednje uvo M 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0
Nasal cavity & middle ear 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.1
C31 Nosni sinusi M 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.5 0.5 0.0 0.0 1.7 0.2
Accessory sinuses 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 1.6 0.1
C32 Larings M 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 7.6 7.7 24.2 28.0 36.1 35.4 35.0 5.5
Larynx 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 1.6 3.2 2.4 0.0 4.2 5.1 0.6
C33 Traheja M 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.9 1.2 0.1
Trachea 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 1.2 0.1
C34 Bronh i plua M 100.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.7 10.4 39.9 107.9 200.6 283.3 347.1 339.9 320.0 51.6
Bronchus & lung 35.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.2 9.7 23.9 42.3 72.2 90.4 89.8 95.2 82.3 17.1
C37 Timus M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0
Thymus 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 1.2 0.1
C38 Srce, mediastinum, pleura M 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.8 0.5 1.9 2.6 5.0 2.7 5.2 0.7
Heart, mediastinum & pleura 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 1.4 1.4 0.7 4.4 0.3
C39 Toraks, druge lokalizacije M 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.1
Other & ill-def. in the res.sys. 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.8 0.1
C40 Kosti i zglobne hrskavice udova M 0.3 0.0 0.0 1.5 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.9 0.6 0.3
Bone & articular cartilage of limbs 0.2 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.2
C41 Kosti i zglobne hrskavice, druge lokalizacije M 1.1 0.0 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.6 0.0 1.1 1.5 1.1 3.4 3.5 5.8 0.6
Bone & articular cartilage of other 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.7 0.7 2.0 0.1
C43 Koa, maligni melanom M 4.2 0.0 0.0 0.0 0.0 0.0 1.1 1.6 1.6 1.7 2.3 5.5 6.8 5.8 10.1 11.5 18.7 2.2
Malignant melanoma of skin 3.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 1.7 1.7 5.2 5.0 3.3 12.2 5.6 8.7 1.5
C44 Koa, drugi maligni tumori M 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 3.7 4.2 8.0 23.3 1.1
Skin, other malignomas 2.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 1.8 1.9 1.4 9.1 15.0 0.7
C45 Mezoteliom M 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 1.0 1.1 4.2 4.4 2.9 0.5
Mesothelioma 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 1.4 0.8 0.1
C46 Kaposijev sarkom M 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0
Kaposi's sarcoma 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1
C47 Periferni nervi i autonomni nervni sistem M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Peripheral nerves & auton. nerv. sys. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
C48 Peritoneum i retroperitoneum M 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 1.0 2.1 0.8 1.8 2.9 0.3
Retroperitoneum & peritoneum 1.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.9 2.9 2.9 5.6 4.7 0.6
C49 Vezivna i meka tkiva, drugi M 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.5 0.5 1.1 0.0 0.0 2.3 0.2
Other connective and soft tissue 0.7 0.8 0.0 0.0 0.7 0.6 0.0 0.6 0.0 1.1 0.0 1.0 0.0 1.9 0.7 1.4 2.0 0.5
C50 Dojka M 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.1 1.7 0.9 4.7 0.3
Breast 43.4 0.0 0.0 0.0 0.0 0.0 0.6 3.9 8.2 19.5 35.3 48.1 71.8 76.6 98.4 98.0 145.6 20.2
Tabela 21.1 Mortalitet od raka na 100.000 stanovnika prema primarnoj lokalizaciji (MKB-10), uzrastu i polu,
Table 21.1 Cancer mortality rates per 100.000 population by primary site (ICD-10), age and sex, Central Serbia, 2012 (continued)
Sirovi Stand.
MKB-10 POL U Z R A S T (A g e )
mort. mort.
(ICD-10 ) Primarna lokalizacija Primary site SEX CR 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ ASR
ifra (Code ) M (Male ) 338.2 5.6 1.5 3.8 4.7 4.3 14.1 12.6 26.7 53.3 115.1 274.5 499.3 721.2 972.3 1238.2 1646.2 164.9
Ukupno (All ) (Female ) 241.5 3.4 3.2 1.6 4.9 1.3 5.2 16.8 35.5 72.2 125.3 221.0 327.1 423.0 516.6 707.8 912.7 105.8
C51 Vulva 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.5 1.8 0.5 1.4 6.3 12.3 0.6
Vulva
C52 Vagina 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.7 2.4 0.1
Vagina
C53 Grli materice 12.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 6.5 9.2 13.7 19.9 20.9 16.7 22.3 35.7 30.5 6.4
Cervix uteri
C54 Materica, telo 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 4.0 7.8 5.5 13.3 15.8 20.3 23.0 2.8
Corpus uteri
C55 Materica, neoznaeni deo 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 2.3 0.5 1.8 2.9 2.2 7.7 8.3 0.8
C56 Jajnik 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 6.3 7.4 11.5 19.1 26.6 26.6 29.4 26.5 5.3
Ovary
C57 enski genitalni organi, drugi neoznaeni organi 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.4 0.7 4.2 4.0 0.3
C58 Placenta 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Placenta
C60 Penis M 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.5 1.1 0.0 0.9 7.0 0.3
Penis
C61 Prostata M 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.2 11.1 29.5 57.1 121.3 273.4 11.4
Prostate
C62 Testis M 0.7 0.0 0.0 0.0 0.0 0.6 1.1 0.0 1.6 2.9 0.0 0.5 1.5 0.5 0.0 0.9 0.6 0.5
Testis
C63 Muki genitalni organi, drugi neoznaeni organi M 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 1.7 0.0 1.7 0.2
C64 Bubreg M 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 7.1 9.2 16.9 20.2 24.8 26.2 3.2
Kidney, except renal pelvis 3.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 1.0 3.2 2.4 10.8 14.7 16.2 1.4
C65 Bubrena karlica M 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 1.8 2.3 0.1
Renal pelvis 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.7 1.2 0.1
C66 Ureter M 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 1.7 0.1
Ureter 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 1.4 0.8 0.1
C67 Mokrana beika M 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 4.1 9.9 12.6 22.7 46.2 50.4 121.8 7.1
Bladder 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 1.6 2.7 5.2 7.2 11.9 22.2 1.4
C68 Urinarni organi, drugi neoznaeni organi M 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0
Other & unspecified urinary organs 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
C69 Oko, pripoji oka M 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 5.2 0.1
Eye and adnexa 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 1.6 0.1
C70 Modanice M 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.5 2.5 2.7 0.6 0.3
Meninges 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.7 1.4 2.4 0.2
C71 Mozak M 10.6 3.2 0.0 1.5 0.7 0.6 2.3 1.1 6.0 4.6 8.8 9.3 16.0 30.1 28.6 39.8 22.7 6.5
Brain 8.2 1.7 1.6 0.0 0.7 0.6 0.6 2.2 2.2 3.4 6.3 7.3 14.5 14.3 20.8 18.9 22.6 4.3
C72 Centralni nervni sistem, drugi delovi M 0.2 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2
Spinal cord, cran. nerv. & oth. parts of CNS 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.1
C73 titasta lezda M 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 1.6 1.0 0.0 1.7 5.3 2.3 0.4
Thyroid gland 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 2.9 0.0 4.2 2.4 0.4
C74 Nadbubrena lezda M 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 1.1 1.7 1.8 2.3 0.2
Adrenal gland 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 1.4 0.7 0.8 0.1
C75 Endokrine lezde, druge M 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 1.6 0.8 0.9 1.2 0.2
Other endocrine glands & related structures 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.1
C76 Ostale lokalizacije M 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 2.4 4.2 2.5 6.2 7.6 0.7
Other & ill defined sites 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 2.6 2.3 5.7 5.0 5.6 17.4 1.2
C77-C80 Sekundarne lokalizacije, bez oznaene lokalizacije M 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.7 2.9 8.8 20.3 28.0 30.3 45.1 61.8 5.8
Unspec.mal.neo. of lymph nod.& without of spec.of site 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 2.3 2.3 6.3 10.9 13.8 18.7 29.4 45.9 3.7
C81 Hodgkinova bolest M 1.1 0.0 0.0 0.0 0.0 0.6 0.6 0.5 1.1 0.6 1.8 0.5 1.5 1.6 5.0 0.9 2.9 0.7
Hodgkin's disease 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.6 0.0 0.0 0.5 0.7 1.4 3.2 0.3
C82 Folikularni ne-Hodgkinov limfom M 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.5 1.0 1.1 4.2 0.0 4.1 0.4
Follicular non-Hodgkin's lymphoma 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.9 0.5 0.7 2.1 4.4 0.3
C83 Difuzni ne-Hodgkinov limfom M 3.0 0.0 0.0 0.0 1.3 0.0 0.6 0.5 0.5 0.6 1.8 2.2 5.3 5.8 9.2 12.4 9.3 1.6
Diffuse non-Hodgkin's lymphoma 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 2.9 3.6 4.9 4.4 0.5
C84 Periferni i koni limfom T-elija M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0
Peripheral & cutaneous T-cell lymphomas 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1
C85 Ne-Hodgkinovi limfomi, drugi M 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 2.7 1.0 1.1 4.2 6.2 8.7 0.7
Other & unspecified types of non-Hodgkin's lymphoma 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 2.7 2.4 0.7 6.3 5.1 0.6
C88 Zloudne imunoproliferativne bolesti M 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0
Malignant immunoproliferative diseases 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0
C90 Multipli mijelom i drugi zloudni tumori plazma elija M 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 4.9 3.4 6.9 7.6 11.5 12.2 1.5
Multiple myeloma and malignant plasma cell neoplasms 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 2.1 2.3 4.8 5.7 9.1 2.4 0.9
C91 Limphoidna leukemija M 4.0 0.0 0.8 0.8 0.0 0.6 0.6 0.5 0.5 1.2 1.8 3.3 4.8 5.3 13.4 13.3 21.0 2.1
Lymphoblastic, lymphoid leukaemia 2.7 0.8 0.8 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.6 2.1 3.6 2.4 7.2 5.6 13.1 1.3
C92 Mijeloidna leukemija M 4.1 1.6 0.8 0.0 0.0 1.2 1.1 0.5 1.6 1.2 1.2 2.7 4.4 5.8 10.9 14.2 21.0 2.3
Myeloid leukaemia 3.2 0.0 0.0 0.0 1.4 0.0 1.2 0.6 1.1 2.3 0.6 5.7 2.3 4.3 5.7 7.7 11.9 1.6
C93 Monocitna leukemija M 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.0 1.8 0.6 0.2
Monocytic leukaemia 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.4 0.1
C94 Leukemije, druge M 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.9 1.2 0.1
Other leukaemias of specified cells 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0
C95 Leukemije, neoznaene M 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 1.7 2.7 2.3 0.2
Leukaemia, unspecified cell type 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.7 2.0 0.1
C96 Drugi zloudni tumori hematopoeznog sistema M 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.5 0.0 0.0 2.7 2.3 0.3
Oth.&unspec.mal.neo. of lymph.,haematopoietic & related tissue 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.7 0.7 0.4 0.1
C00-C96 Sve lokalizacije, bez koe M 335.6 5.6 1.5 3.8 4.7 4.3 14.1 12.6 26.7 53.3 115.1 273.4 496.4 717.5 968.1 1230.2 1622.9 163.9
(C44) All sites but skin 239.2 3.4 3.2 1.6 4.9 1.3 4.7 16.8 35.5 72.2 125.3 220.5 325.3 421.0 515.1 698.7 897.6 105.0
Tabela 22. Ukupan broj novoobolelih, broj i procenat histoloki i citoloki verifikovanih sluajeva raka
prema primarnoj lokalizaciji i polu, centralna Srbija, 2012. godina
Table 22. Total number of new cancer cases, number and percentage of histologically and cytologically confirmed cancer cases
by primary site and sex, Central Serbia 2012
MKB-10 POL Ukupan broj novoobolelih Broj histo. / cito. verifikovanih

%
(ICD-10) Primarna lokalizacija SEX All new cases Number of cases histo./ cyto. confirmed
ifra (Code ) Primary site M (Male ) 13860 11866 85.6%
C00 Usna M 77 70 90.9%
Lip 21 20 95.2%
C01 Jezik, koren M 23 20 87.0%
Base of tongue 6 5 83.3%
C02 Jezik, drugi delovi M 40 31 77.5%
Tongue, other & unspecified parts 11 7 63.6%
C03 Desni M 6 4 66.7%
Gum 2 1 50.0%
C04 Pod usta M 49 29 59.2%
Floor of mouth 14 10 71.4%
C05 Nepce M 17 14 82.4%
Palate 2 1 50.0%
C06 Usta, drugi delovi M 12 10 83.3%
Mouth, other & unspecified parts 33 27 81.8%
C07 Parotidna lezda M 21 21 100.0%
Parotid gland 14 11 78.6%
C08 Pljuvana lezda M 12 6 50.0%
Other & unspec. major salivary gl. 11 5 45.5%
C09 Krajnik M 32 28 87.5%
Tonsil 8 6 75.0%
C10 Orofarings M 37 12 32.4%
Oropharynx 25 14 56.0%
C11 Nasofarings M 54 11 20.4%
Nasopharynx 12 8 66.7%
C12 Piriformni sinus M 4 2 50.0%
Pyriform sinus 0 0 0.0%
C13 Hipofarings M 74 50 67.6%
Hypopharynx 8 7 87.5%
C14 Usne, usta, drelo, drugi delovi M 18 7 38.9%
Other and ill def. sites in the lip, oral cavity & pharynx 13 2 15.4%
C15 Jednjak M 167 115 68.9%
Oesophagus 24 19 79.2%
C16 eludac M 517 500 96.7%
Stomach 255 250 98.0%
C17 Tanko crevo M 32 11 34.4%
Small intestine 26 10 38.5%
C18 Debelo crevo M 986 753 76.4%
Colon 605 506 83.6%
C19 Rektosigmoidni prelaz M 112 99 88.4%
Rectosigmoid junction 95 75 78.9%
C20 Rektum M 623 620 99.5%
Rectum 353 350 99.2%
C21 Anus i analni kanal M 21 15 71.4%
Anus & anal canal 8 6 75.0%
C22 Jetra, uni kanali M 233 230 98.7%
Liver & intrahepatic bile ducts 185 180 97.3%
C23 una kesa M 28 20 71.4%
Gallbladder 73 65 89.0%
C24 uni kanali, drugi delovi M 18 17 94.4%
Billiary tract, other & unspec. parts 33 30 90.9%
C25 Pankreas M 322 270 83.9%
Pancreas 272 250 91.9%
C26 Organi za varenje, nedovoljno odredjene lokalizacije M 19 10 52.6%
Other & ill-defined digestive organs 24 14 58.3%
C30 Nosna upljina i srednje uvo M 20 10 50.0%
Nasal cavity & middle ear 12 10 83.3%
C31 Nosni sinusi M 23 10 43.5%
Accessory sinuses 6 3 50.0%
C32 Larings M 458 450 98.3%
Larynx 54 50 92.6%
C33 Traheja M 6 5 83.3%
Trachea 2 1 50.0%
C34 Bronh i plua M 3117 2539 81.5%
Bronchus & lung 959 800 83.4%
C37 Timus M 0 0 0.0%
Thymus 0 0 0.0%
C38 Srce, mediastinum, pleura M 44 40 90.9%
Heart, mediastinum & pleura 17 15 88.2%
C39 Toraks, druge lokalizacije M 2 2 100.0%
Other & ill-def. in the res.sys. 2 2 100.0%
C40 Kosti i zglobne hrskavice udova M 53 25 47.2%
Bone & articular cartilage of limbs 43 21 48.8%
C41 Kosti i zglobne hrskavice, druge lokalizacije M 32 22 68.8%
Bone & articular cartilage of other 32 22 68.8%
C43 Koa, maligni melanom M 241 202 83.8%
Malignant melanoma of skin 220 184 83.6%
C44 Koa, drugi maligni tumori M 1622 1337 82.4%
Skin, other malignomas 1507 1132 75.1%
C45 Mezoteliom M 8 5 62.5%
Mesothelioma 2 0 0.0%
C46 Kaposijev sarkom M 2 1 50.0%
Kaposi's sarcoma 3 2 66.7%
C47 Periferni nervi i autonomni nervni sistem M 9 4 44.4%
Peripheral nerves & auton. nerv. sys. 9 3 33.3%
C48 Peritoneum i retroperitoneum M 26 21 80.8%
Retroperitoneum & peritoneum 34 20 58.8%
C49 Vezivna i meka tkiva, drugi M 65 44 67.7%
Other connective and soft tissue 88 57 64.8%
C50 Dojka M 61 50 82.0%
Breast 3186 2723 85.5%
Tabela 22.1 Ukupan broj novoobolelih, broj i procenat histoloki i citoloki verifikovanih sluajeva raka
prema primarnoj lokalizaciji i polu, centralna Srbija, 2012. godina (nastavak)
Table 22.1 Total number of new cancer cases, number and percentage of histologically and cytologically confirmed cancer cases
by primary site and sex, Central Serbia 2012 (continued)
MKB-10 POL Ukupan broj novoobolelih Broj histo. / cito. verifikovanih

%
(ICD-10) Primarna lokalizacija SEX All new cases Number of cases histo./ cyto. confirmed
ifra (Code ) Primary site M (Male ) 13860 11866 85.6%
C51 Vulva 80 75 93.8%
Vulva
C52 Vagina 25 21 84.0%
Vagina
C53 Grli materice 986 906 91.9%
Cervix uteri
C54 Materica, telo 722 700 97.0%
Corpus uteri
C55 Materica, neoznaeni deo 22 20 90.9%
C56 Jajnik 453 450 99.3%
Ovary
C57 enski genitalni organi, drugi neoznaeni organi 20 16 80.0%
C58 Placenta 0 0 0.0%
Placenta
C60 Penis M 44 33 75.0%
Penis
C61 Prostata M 1748 1700 97.3%
Prostate
C62 Testis M 196 180 91.8%
Testis
C63 Muki genitalni organi, drugi neoznaeni organi M 5 3 60.0%
C64 Bubreg M 293 250 85.3%
Kidney, except renal pelvis 168 160 95.2%
C65 Bubrena karlica M 23 20 87.0%
Renal pelvis 11 10 90.9%
C66 Ureter M 14 12 85.7%
Ureter 13 11 84.6%
C67 Mokrana beika M 775 692 89.3%
Bladder 262 215 82.1%
C68 Urinarni organi, drugi neoznaeni organi M 2 1 50.0%
Other & unspecified urinary organs 9 5 55.6%
C69 Oko, pripoji oka M 25 20 80.0%
Eye and adnexa 30 22 73.3%
C70 Modanice M 18 11 61.1%
Meninges 21 15 71.4%
C71 Mozak M 314 285 90.8%
Brain 261 239 91.6%
C72 Centralni nervni sistem, drugi delovi M 12 9 75.0%
Spinal cord, cran. nerv. & oth. parts of CNS 2 1 50.0%
C73 titasta lezda M 63 55 87.3%
Thyroid gland 161 150 93.2%
C74 Nadbubrena lezda M 11 10 90.9%
Adrenal gland 16 14 87.5%
C75 Endokrine lezde, druge M 10 6 60.0%
Other endocrine glands & related structures 5 3 60.0%
C76 Ostale lokalizacije M 48 38 79.2%
Other & ill defined sites 53 43 81.1%
C77-C80 Sekundarne lokalizacije, bez oznaene lokalizacije M 314 210 66.9%
Unspec.mal.neo. of lymph nod.& without of spec.of site 209 140 67.0%
C81 Hodgkinova bolest M 69 67 97.1%
Hodgkin's disease 56 55 98.2%
C82 Folikularni ne-Hodgkinov limfom M 40 39 97.5%
Follicular non-Hodgkin's lymphoma 62 61 98.4%
C83 Difuzni ne-Hodgkinov limfom M 113 112 99.1%
Diffuse non-Hodgkin's lymphoma 94 93 98.9%
C84 Periferni i koni limfom T-elija M 4 3 75.0%
Peripheral & cutaneous T-cell lymphomas 5 4 80.0%
C85 Ne-Hodgkinovi limfomi, drugi M 73 72 98.6%
Other & unspecified types of non-Hodgkin's lymphoma 61 60 98.4%
C88 Zloudne imunoproliferativne bolesti M 8 7 0.0%
Malignant immunoproliferative diseases 6 5 83.3%
C90 Multipli mijelom i drugi zloudni tumori plazma elija M 85 85 100.0%
Multiple myeloma and malignant plasma cell neoplasms 78 77 98.7%
C91 Limphoidna leukemija M 106 106 100.0%
Lymphoblastic, lymphoid leukaemia 76 76 100.0%
C92 Mijeloidna leukemija M 86 85 98.8%
Myeloid leukaemia 69 68 98.6%
C93 Monocitna leukemija M 3 3 100.0%
Monocytic leukaemia 4 4 100.0%
C94 Leukemije, druge M 1 1 100.0%
Other leukaemias of specified cells 1 1 100.0%
C95 Leukemije, neoznaene M 11 11 100.0%
Leukaemia, unspecified cell type 8 8 100.0%
C96 Drugi zloudni tumori hematopoeznog sistema M 3 3 100.0%
Oth.&unspec.mal.neo. of lymph.,haematopoietic & related tissue 0 0 0.0%
C00-C96 Sve lokalizacije, bez koe M 12238 10529 86.0%
(C44) All sites but skin 10851 9520 87.7%
Tabela 23. Broj novoobolelih i incidencija od raka na 100.000 stanovnika prema primarnoj lokalizaciji,
Table 23. Number of new cancer cases and cancer incidence rates per 100.000 population by primary site,
MKB-10 POL Ukupno Sirova incid. Standardizovana incidencija (Stand. incidence )

(ICD-10) Primarna lokalizacija SEX (All ) Crude rate ASR(E) ASR(W) TRUNC
ifra (Code ) Primary site M (Male ) 13860 539.2 406.9 289.5 142.0
Ukupno (All ) (Female ) 12358 456.6 332.5 246.7 153.3
C00 Usna M 77 3.0 2.3 1.6 0.9
Lip 21 0.8 0.4 0.3 0.1
C01 Jezik, koren M 23 0.9 0.7 0.5 0.5
Base of tongue 6 0.2 0.2 0.1 0.1
C02 Jezik, drugi delovi M 40 1.6 1.2 0.9 0.8
Tongue, other & unspecified parts 11 0.4 0.3 0.2 0.1
C03 Desni M 6 0.2 0.2 0.1 0.1
Gum 2 0.1 0.1 0.1 0.1
C04 Pod usta M 49 1.9 1.5 1.1 0.9
Floor of mouth 14 0.5 0.4 0.3 0.2
C05 Nepce M 17 0.7 0.6 0.4 0.3
Palate 2 0.1 0.1 0.1 0.0
C06 Usta, drugi delovi M 12 0.5 0.3 0.2 0.1
Mouth, other & unspecified parts 33 1.2 1.1 0.9 0.7
C07 Parotidna lezda M 21 0.8 0.6 0.4 0.2
Parotid gland 14 0.5 0.4 0.3 0.2
C08 Pljuvana lezda M 12 0.5 0.3 0.2 0.0
Other & unspec. major salivary gl. 11 0.4 0.3 0.2 0.1
C09 Krajnik M 32 1.2 0.9 0.6 0.4
Tonsil 8 0.3 0.2 0.1 0.0
C10 Orofarings M 37 1.4 1.2 0.9 0.7
Oropharynx 25 0.9 0.6 0.4 0.3
C11 Nasofarings M 54 2.1 1.9 1.6 1.1
Nasopharynx 12 0.4 0.3 0.2 0.1
C12 Piriformni sinus M 4 0.2 0.1 0.1 0.0
Pyriform sinus 0 0.0 0.0 0.0 0.0
C13 Hipofarings M 74 2.9 2.3 1.7 1.1
Hypopharynx 8 0.3 0.2 0.2 0.2
C14 Usne, usta, drelo, drugi delovi M 18 0.7 0.5 0.4 0.2
Other & ill def. sites in the lip oral cavity & pharynx 13 0.5 0.4 0.2 0.2
C15 Jednjak M 167 6.5 4.9 3.5 2.4
Oesophagus 24 0.9 0.6 0.5 0.2
C16 eludac M 517 20.1 14.9 10.2 5.2
Stomach 255 9.4 6.1 4.2 1.9
C17 Tanko crevo M 32 1.2 0.9 0.6 0.3
Small intestine 26 1.0 0.6 0.5 0.3
C18 Debelo crevo M 986 38.4 28.6 19.9 9.4
Colon 605 22.4 15.3 10.9 6.4
C19 Rektosigmoidni prelaz M 112 4.4 3.3 2.3 1.1
Rectosigmoid junction 95 3.5 2.3 1.6 0.9
C20 Rektum M 623 24.2 18.0 12.4 6.2
Rectum 353 13.0 8.3 5.7 2.8
C21 Anus i analni kanal M 21 0.8 0.6 0.4 0.3
Anus & anal canal 8 0.3 0.2 0.1 0.1
C22 Jetra, uni kanali M 233 9.1 6.6 4.6 1.9
Liver & intrahepatic bile ducts 185 6.8 4.1 2.7 1.0
C23 u~na kesa M 28 1.1 0.8 0.6 0.3
Gallbladder 73 2.7 1.6 1.1 0.4
C24 u~ni kanali, drugi delovi M 18 0.7 0.5 0.3 0.2
Billiary tract, other & unspec. parts 33 1.2 0.9 0.6 0.4
C25 Pankreas M 322 12.5 9.3 6.4 3.4
Pancreas 272 10.0 6.3 4.4 2.2
C26 Org. za var., neodre. lok. M 19 0.7 0.5 0.3 0.2
Other & ill-defined digestive organs 24 0.9 0.5 0.3 0.1
C30 Nosna upljina i srednje uvo M 20 0.8 0.6 0.5 0.2
Nasal cavity & middle ear 12 0.4 0.3 0.2 0.1
C31 Nosni sinusi M 23 0.9 0.7 0.5 0.4
Accessory sinuses 6 0.2 0.1 0.1 0.1
C32 Larings M 458 17.8 13.9 10.1 6.5
Larynx 54 2.0 1.4 1.0 0.7
C33 Traheja M 6 0.2 0.2 0.1 0.1
Trachea 2 0.1 0.1 0.1 0.0
C34 Bronh i plua M 3117 121.3 92.0 65.0 39.6
Bronchus & lung 959 35.4 25.3 18.2 12.5
C37 Timus M 0 0.0 0.0 0.0 0.0
Thymus 0 0.0 0.0 0.0 0.0
C38 Srce, mediastinum, pleura M 44 1.7 1.4 1.0 0.6
Heart, mediastinum & pleura 17 0.6 0.4 0.3 0.1
C39 Toraks, druge lokalizacije M 2 0.1 0.0 0.0 0.0
Other & ill-def. in the res. sys. & intrath. org. 2 0.1 0.1 0.0 0.0
C40 Kosti i zglob. hrskavice udova M 53 2.1 2.2 2.5 0.4
Bone & articular cartilage of limbs 43 1.6 1.8 2.0 0.3
C41 Kosti i zglob. hrskav., dr. lok. M 32 1.2 1.1 1.0 0.4
Bone & artic. cart. of other & unspec. parts 32 1.2 0.9 0.8 0.3
C43 Koa, maligni melanom M 241 9.4 7.2 5.1 2.8
Malignant melanoma of skin 220 8.1 6.2 4.7 2.8
C44 Koa, drugi mal. tumori M 1622 63.1 45.5 30.7 12.2
Skin, other malignomas 1507 55.7 35.0 24.2 10.5
C45 Mezoteliom M 8 0.3 0.2 0.2 0.1
Mesothelioma 2 0.1 0.1 0.0 0.0
C46 Kaposijev sarkom M 2 0.1 0.1 0.0 0.0
Kaposi's sarcoma 3 0.1 0.1 0.2 0.1
C47 Periferni nervi i aut. ner. sis. M 9 0.4 0.4 0.4 0.1
Peripheral nerves & auton. nerv. sys. 9 0.3 0.2 0.2 0.1
C48 Peritoneum i retroperitoneum M 26 1.0 0.8 0.6 0.4
Retroperitoneum & peritoneum 34 1.3 1.0 0.7 0.6
C49 Vezivna i meka tkiva, drugi M 65 2.5 2.2 1.8 1.1
Other connective and soft tissue 88 3.3 2.7 2.1 1.4
C50 Dojka M 61 2.4 1.8 1.3 0.6
Breast 3186 117.7 91.3 68.3 50.7
Tabela 23.1 Broj novoobolelih i incidencija od raka na 100.000 stanovnika prema primarnoj lokalizaciji,
uzrastu i polu, centralna Srbija, 2012. godina (nastavak)
Table 23.1 Number of new cancer cases and cancer incidence rates per 100.000 population by primary site,
age and sex, Central Serbia, 2012 (continued)
MKB-10 POL Ukupno Sirova incid. Standardizovana incidencija (Stand. incidence )

C51 Vulva 80 3.0 1.7 1.1 0.5
Vulva
C52 Vagina 25 0.9 0.6 0.5 0.3
Vagina
C53 Grli materice 986 36.4 30.2 23.2 17.8
Cervix uteri
C54 Materica, telo 722 26.7 19.2 13.8 9.4
Corpus uteri
C55 Materica, neoznaeni deo 22 0.8 0.6 0.4 0.3
C56 Jajnik 453 16.7 13.1 10.2 6.7
Ovary
C57 enski gen. org., dr. neoz. lok. 20 0.7 0.5 0.3 0.2
Other & unspec. parts of fem. gen. org.
C58 Placenta 0 0.0 0.0 0.0 0.0
Placenta
C60 Penis M 44 1.7 1.3 0.9 0.5
Penis
C61 Prostata M 1748 68.0 46.7 30.0 7.5
Prostate
C62 Testis M 196 7.6 7.6 7.3 2.5
Testis
C63 Muki gen. org., dr. neoz. org. M 5 0.2 0.2 0.1 0.0
C64 Bubreg M 293 11.4 8.9 6.5 3.9
Kidney, except renal pelvis 168 6.2 4.4 3.2 1.9
C65 Bubrena karlica M 23 0.9 0.6 0.5 0.3
Renal pelvis 11 0.4 0.3 0.2 0.1
C66 Ureter M 14 0.5 0.4 0.3 0.2
Ureter 13 0.5 0.3 0.2 0.1
C67 Mokrana beika M 775 30.2 22.1 15.1 7.3
Bladder 262 9.7 6.3 4.4 2.5
C68 Urinarni organi, dr. neoz. org. M 2 0.1 0.1 0.1 0.0
Other & unspecified urinary organs 9 0.3 0.2 0.1 0.0
C69 Oko, pripoji oka M 25 1.0 0.8 0.6 0.3
Eye and adnexa 30 1.1 0.8 0.6 0.3
C70 Modanice M 18 0.7 0.6 0.4 0.2
Meninges 21 0.8 0.5 0.4 0.2
C71 Mozak M 314 12.2 10.2 8.4 3.9
Brain 261 9.6 7.8 6.8 2.6
C72 Centralni ner. sis., dr. delovi M 12 0.5 0.5 0.6 0.1
Spinal cord, cran. nerv. & oth. parts of CNS 2 0.1 0.1 0.1 0.0
C73 titasta lezda M 63 2.5 2.1 1.7 1.0
Thyroid gland 161 5.9 5.1 4.1 2.7
C74 Nadbubrena lezda M 11 0.4 0.4 0.3 0.1
Adrenal gland 16 0.6 0.6 0.6 0.2
C75 Endokrine lezde, druge M 10 0.4 0.3 0.3 0.1
Oth. endoc. gl. & related structures 5 0.2 0.1 0.1 0.0
C76 Ostale lokalizacije M 48 1.9 1.4 1.0 0.5
Other & ill defined sites 53 2.0 1.2 0.9 0.3
C77-C80 Sekundarne lok., bez ozn. lok. M 314 12.2 9.4 7.1 3.3
Unspec.mal.neo. of lymph nod.& without of spec.of site 209 7.7 5.5 4.1 2.3
C81 Hodgkinova bolest M 69 2.7 2.6 2.5 1.0
Hodgkin's disease 56 2.1 2.0 1.9 0.5
C82 Ne-Hodgkinov lim., folikularni M 40 1.6 1.2 0.9 0.7
Follicular non-Hodgkin's lymphoma 62 2.3 1.9 1.5 0.9
C83 Ne-Hodgkinov lim., difuzni M 113 4.4 3.5 2.5 1.3
Diffuse non-Hodgkin's lymphoma 94 3.5 2.5 1.9 0.9
C84 Periferni i koni lim. T-elija M 4 0.2 0.1 0.1 0.0
Peripheral & cutaneous T-cell lymphomas 5 0.2 0.1 0.1 0.1
C85 Ne-Hodgkinovi limfomi, drugi M 73 2.8 2.3 1.7 0.9
Oth. & unspec. types of non-Hodgkin's lymphoma 61 2.3 1.5 1.0 0.5
C88 Zloudne imunoprolifer. bolesti M 8 0.3 0.2 0.2 0.1
Malignant immunoproliferative diseases 6 0.2 0.2 0.1 0.1
C90 Mult. mijelom i zlo. tum. plaz. el. M 85 3.3 2.6 1.9 1.0
Multiple myeloma and malignant plasma cell neoplasms 78 2.9 2.0 1.5 0.8
C91 Limfoidna leukemija M 106 4.1 3.5 3.1 0.9
Lymphoblastic, lymphoid leukaemia 76 2.8 2.2 2.0 0.5
C92 Mijeloidna leukemija M 86 3.3 2.6 1.8 0.7
Myeloid leukaemia 69 2.5 2.0 1.6 0.9
C93 Monocitna leukemija M 3 0.1 0.1 0.1 0.0
Monocytic leukaemia 4 0.1 0.1 0.1 0.1
C94 Leukemije, druge M 1 0.0 0.0 0.0 0.0
Other leukaemias of specified cells 1 0.0 0.0 0.0 0.0
C95 Leukemije, neozna~ene M 11 0.4 0.3 0.3 0.1
Leukaemia, unspecified cell type 8 0.3 0.3 0.3 0.1
C96 Dr. zlo. tum. hematop. sist. M 3 0.1 0.1 0.1 0.0
Oth.&unspec.mal.neo. of lymph.,haematopoietic & related tissue 0 0.0 0.0 0.0 0.0
C00-C96 Sve lokalizacije, bez koe M 12238 476.1 361.3 258.7 129.7
(C44) All sites but skin 10851 400.9 297.5 222.6 142.8
Tabela 24. Broj umrlih i mortalitet od raka na 100.000 stanovnika prema primarnoj lokalizaciji,
Table 24. Number of death cancer cases and cancer mortality rates per 100.000 population by primary site,
MKB-10 POL Ukupno Sirovi mort. Standardizovani mortalitet (Stand. mortality )

C00 Usna M 8 0.3 0.2 0.1 0.0
Lip 10 0.4 0.2 0.1 0.0
C01 Jezik, koren M 22 0.9 0.7 0.5 0.3
Base of tongue 4 0.1 0.1 0.1 0.0
C02 Jezik, drugi delovi M 35 1.4 1.1 0.8 0.6
Tongue, other & unspecified parts 8 0.3 0.2 0.1 0.0
C03 Desni M 3 0.1 0.1 0.1 0.1
Gum 1 0.0 0.0 0.0 0.0
C04 Pod usta M 27 1.1 0.9 0.6 0.5
Floor of mouth 7 0.3 0.1 0.1 0.0
C05 Nepce M 3 0.1 0.1 0.1 0.0
Palate 3 0.1 0.1 0.0 0.0
C06 Usta, drugi delovi M 7 0.3 0.2 0.1 0.1
Mouth, other & unspecified parts 1 0.0 0.0 0.0 0.0
C07 Parotidna lezda M 12 0.5 0.3 0.2 0.1
Parotid gland 4 0.1 0.1 0.1 0.0
C08 Pljuvana lezda M 5 0.2 0.2 0.1 0.1
Other & unspec. major salivary gl. 5 0.2 0.1 0.1 0.1
C09 Krajnik M 20 0.8 0.6 0.4 0.3
Tonsil 4 0.1 0.1 0.1 0.0
C10 Orofarings M 25 1.0 0.8 0.5 0.4
Oropharynx 6 0.2 0.2 0.1 0.1
C11 Nasofarings M 20 0.8 0.6 0.4 0.3
Nasopharynx 10 0.4 0.2 0.1 0.1
C12 Piriformni sinus M 0 0.0 0.0 0.0 0.0
Pyriform sinus 0 0.0 0.0 0.0 0.0
C13 Hipofarings M 53 2.1 1.6 1.1 0.7
Hypopharynx 9 0.3 0.3 0.2 0.1
C14 Usne, usta, drelo, drugi delovi M 11 0.4 0.4 0.3 0.1
Other & ill def. sites in the lip oral cavity & pharynx 5 0.2 0.1 0.1 0.0
C15 Jednjak M 160 6.2 4.7 3.2 1.9
Oesophagus 31 1.1 0.7 0.5 0.3
C16 eludac M 497 19.3 13.8 9.2 4.3
Stomach 311 11.5 6.8 4.4 2.0
C17 Tanko crevo M 17 0.7 0.4 0.3 0.1
Small intestine 11 0.4 0.2 0.2 0.1
C18 Debelo crevo M 569 22.1 15.5 10.1 3.3
Colon 379 14.0 8.2 5.4 2.1
C19 Rektosigmoidni prelaz M 67 2.6 1.8 1.2 0.5
Rectosigmoid junction 47 1.7 1.0 0.7 0.3
C20 Rektum M 498 19.4 13.6 8.9 3.0
Rectum 306 11.3 6.7 4.4 1.9
C21 Anus i analni kanal M 9 0.4 0.3 0.2 0.1
Anus & anal canal 10 0.4 0.2 0.2 0.1
C22 Jetra, uni kanali M 283 11.0 7.8 5.1 1.7
Liver & intrahepatic bile ducts 233 8.6 5.0 3.3 1.4
C23 una kesa M 40 1.6 1.1 0.7 0.3
Gallbladder 109 4.0 2.3 1.5 0.5
C24 uni kanali, drugi delovi M 56 2.2 1.5 1.0 0.4
Billiary tract, other & unspec. parts 39 1.4 0.9 0.6 0.2
C25 Pankreas M 441 17.2 12.3 8.1 3.5
Pancreas 386 14.3 8.3 5.4 2.0
C26 Org. za var., neodre. lok. M 23 0.9 0.6 0.4 0.1
Other & ill-defined digestive organs 33 1.2 0.7 0.4 0.2
C30 Nosna upljina i srednje uvo M 4 0.2 0.1 0.0 0.0
Nasal cavity & middle ear 6 0.2 0.1 0.1 0.1
C31 Nosni sinusi M 9 0.4 0.3 0.2 0.1
Accessory sinuses 6 0.2 0.1 0.1 0.0
C32 Larings M 276 10.7 7.9 5.5 3.0
Larynx 37 1.4 0.9 0.6 0.4
C33 Traheja M 7 0.3 0.2 0.1 0.1
Trachea 6 0.2 0.1 0.1 0.0
C34 Bronh i plua M 2588 100.7 74.4 51.6 27.9
Bronchus & lung 963 35.6 24.1 17.1 10.8
C37 Timus M 1 0.0 0.0 0.0 0.0
Thymus 5 0.2 0.1 0.1 0.0
C38 Srce, mediastinum, pleura M 33 1.3 1.0 0.7 0.4
Heart, mediastinum & pleura 20 0.7 0.4 0.3 0.2
C39 Toraks, druge lokalizacije M 3 0.1 0.1 0.1 0.1
Other & ill-def. in the res. sys. & intrath. org. 5 0.2 0.1 0.1 0.0
C40 Kosti i zglob. hrskavice udova M 8 0.3 0.3 0.3 0.0
Bone & articular cartilage of limbs 6 0.2 0.2 0.2 0.0
C41 Kosti i zglob. hrskav., dr. lok. M 29 1.1 0.9 0.6 0.2
Bone & artic. cart. of other & unspec. parts 9 0.3 0.2 0.1 0.1
C43 Koa, maligni melanom M 107 4.2 3.2 2.2 1.1
Malignant melanoma of skin 83 3.1 2.2 1.5 0.8
C44 Koa, drugi mal. tumori M 69 2.7 1.8 1.1 0.3
Skin, other malignomas 63 2.3 1.2 0.7 0.2
C45 Mezoteliom M 22 0.9 0.6 0.5 0.2
Mesothelioma 7 0.3 0.1 0.1 0.0
C46 Kaposijev sarkom M 2 0.1 0.0 0.0 0.0
Kaposi's sarcoma 1 0.0 0.0 0.1 0.0
C47 Periferni nervi i aut. ner. sis. M 0 0.0 0.0 0.0 0.0
Peripheral nerves & auton. nerv. sys. 0 0.0 0.0 0.0 0.0
C48 Peritoneum i retroperitoneum M 17 0.7 0.5 0.3 0.2
Retroperitoneum & peritoneum 35 1.3 0.8 0.6 0.2
C49 Vezivna i meka tkiva, drugi M 10 0.4 0.3 0.2 0.1
Other connective and soft tissue 20 0.7 0.6 0.5 0.2
C50 Dojka M 19 0.7 0.5 0.3 0.2
Breast 1175 43.4 28.9 20.2 12.1
Tabela 24.1 Broj umrlih i mortalitet od raka na 100.000 stanovnika prema primarnoj lokalizaciji, uzrastu i polu,
Table 24.1 Number of death cancer cases and cancer mortality rates per 100.000 population by primary site,
age and sex, Central Serbia, 2012 (continued)
MKB-10 POL Ukupno Sirovi mort. Standardizovani mortalitet (Stand. mortality )

C51 Vulva 51 1.9 1.7 0.6 0.5
Vulva
C52 Vagina 9 0.3 0.6 0.1 0.3
Vagina
C53 Grli materice 334 12.3 30.2 6.4 17.8
Cervix uteri
C54 Materica, telo 174 6.4 19.2 2.8 9.4
Corpus uteri
C55 Materica, neoznaeni deo 53 2.0 0.6 0.8 0.3
C56 Jajnik 294 10.9 13.1 5.3 6.7
Ovary
C57 enski gen. org., dr. neoz. lok. 23 0.8 0.5 0.3 0.2
Other & unspec. parts of fem. gen. org.
C58 Placenta 0 0.0 0.0 0.0 0.0
Placenta
C60 Penis M 18 0.7 1.3 0.3 0.5
Penis
C61 Prostata M 758 29.5 46.7 11.4 7.5
Prostate
C62 Testis M 18 0.7 7.6 0.5 2.5
Testis
C63 Muki gen. org., dr. neoz. org. M 8 0.3 0.2 0.2 0.0
C64 Bubreg M 167 6.5 8.9 3.2 3.9
Kidney, except renal pelvis 95 3.5 4.4 1.4 1.9
C65 Bubrena karlica M 8 0.3 0.6 0.1 0.3
Renal pelvis 6 0.2 0.3 0.1 0.1
C66 Ureter M 5 0.2 0.4 0.1 0.2
Ureter 6 0.2 0.3 0.1 0.1
C67 Mokrana beika M 418 16.3 22.1 7.1 7.3
Bladder 106 3.9 6.3 1.4 2.5
C68 Urinarni organi, dr. neoz. org. M 2 0.1 0.1 0.0 0.0
Other & unspecified urinary organs 0 0.0 0.2 0.0 0.0
C69 Oko, pripoji oka M 11 0.4 0.8 0.1 0.3
Eye and adnexa 10 0.4 0.8 0.1 0.3
C70 Modanice M 11 0.4 0.6 0.3 0.2
Meninges 12 0.4 0.5 0.2 0.2
C71 Mozak M 273 10.6 10.2 6.5 3.9
Brain 221 8.2 7.8 4.3 2.6
C72 Centralni ner. sis., dr. delovi M 4 0.2 0.5 0.2 0.1
Spinal cord, cran. nerv. & oth. parts of CNS 3 0.1 0.1 0.1 0.0
C73 titasta lezda M 19 0.7 2.1 0.4 1.0
Thyroid gland 24 0.9 5.1 0.4 2.7
C74 Nadbubrena lezda M 13 0.5 0.4 0.2 0.1
Adrenal gland 8 0.3 0.6 0.1 0.2
C75 Endokrine lezde, druge M 9 0.4 0.3 0.2 0.1
Oth. endoc. gl. & related structures 3 0.1 0.1 0.1 0.0
C76 Ostale lokalizacije M 39 1.5 1.4 0.7 0.5
Other & ill defined sites 85 3.1 1.2 1.2 0.3
C77-C80 Sekundarne lok., bez ozn. lok. M 315 12.3 9.4 5.8 3.3
Unspec.mal.neo. of lymph nod.& without of spec.of site 260 9.6 5.5 3.7 2.3
C81 Hodgkinova bolest M 28 1.1 2.6 0.7 1.0
Hodgkin's disease 17 0.6 2.0 0.3 0.5
C82 Ne-Hodgkinov lim., folikularni M 20 0.8 1.2 0.4 0.7
Follicular non-Hodgkin's lymphoma 20 0.7 1.9 0.3 0.9
C83 Ne-Hodgkinov lim., difuzni M 76 3.0 3.5 1.6 1.3
Diffuse non-Hodgkin's lymphoma 34 1.3 2.5 0.5 0.9
C84 Periferni i koni lim. T-elija M 1 0.0 0.1 0.0 0.0
Peripheral & cutaneous T-cell lymphomas 2 0.1 0.1 0.1 0.1
C85 Ne-Hodgkinovi limfomi, drugi M 38 1.5 2.3 0.7 0.9
Oth. & unspec. types of non-Hodgkin's lymphoma 38 1.4 1.5 0.6 0.5
C88 Zloudne imunoprolifer. bolesti M 2 0.1 0.2 0.0 0.1
Malignant immunoproliferative diseases 3 0.1 0.2 0.0 0.1
C90 Mult. mijelom i zlo. tum. plaz. el. M 75 2.9 2.6 1.5 1.0
Multiple myeloma and malignant plasma cell neoplasms 49 1.8 2.0 0.9 0.8
C91 Limfoidna leukemija M 104 4.0 3.5 2.1 0.9
Lymphoblastic, lymphoid leukaemia 73 2.7 2.2 1.3 0.5
C92 Mijeloidna leukemija M 105 4.1 2.6 2.3 0.7
Myeloid leukaemia 86 3.2 2.0 1.6 0.9
C93 Monocitna leukemija M 7 0.3 0.1 0.2 0.0
Monocytic leukaemia 5 0.2 0.1 0.1 0.1
C94 Leukemije, druge M 5 0.2 0.0 0.1 0.0
Other leukaemias of specified cells 1 0.0 0.0 0.0 0.0
C95 Leukemije, neoznaene M 11 0.4 0.3 0.2 0.1
Leukaemia, unspecified cell type 8 0.3 0.3 0.1 0.1
C96 Dr. zlo. tum. hematop. sist. M 11 0.4 0.1 0.3 0.0
Oth.&unspec.mal.neo. of lymph.,haematopoietic & related tissue 5 0.2 0.0 0.1 0.0
C00-C96 Sve lokalizacije, bez koe M 8625 335.6 242.3 163.9 73.9
(C44) All sites but skin 6474 239.2 152.3 105.0 54.9

2012IncidencijaIMortalitetOdRaka1 PDF

Uploaded by

Copyright:

Available Formats

2012IncidencijaIMortalitetOdRaka1 PDF

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

2012IncidencijaIMortalitetOdRaka1 PDF

Uploaded by

Copyright:

Available Formats

Institut za javno zdravlje Srbije Dr Milan Jovanovi Batut

Institute of Public Health of Serbia Dr Milan Jovanovi Batut

INCIDENCIJA I MORTALITET OD RAKA

REGISTAR ZA RAK U CENTRALNOJ SRBIJI

Odeljenje za prevenciju i kontrolu nezaraznih bolesti

INCIDENCIJA I MORTALITET OD RAKA

REGISTAR ZA RAK U CENTRALNOJ SRBIJI

Odeljenje za prevenciju i kontrolu nezaraznih bolesti

Dizajn i priprema za tampu

Informatika podrka / IT support

Institut za javno zdravlje Srbije

Registar za rak centralne Srbije predstavlja najznaajniji izvor podataka o obolevanju i

Beograd, 30.10.2013. godine

Medicinski fakultet Univerzitet u Beogradu

Prof. dr Tatjana Pekmezovi

Populacioni registar za rak je najstariji registar u Srbiji i ima neprocenjiv znaaj za

Poseban akcenat treba staviti na kvalitet Registra, koji je rezultat decentralizovanog

Autori su na originalan i sistematizovan nain prikazali podatke o obolevanju i umiranju od raka.

Ukupno uzevi ova publikacija zasluuje pohvale ne samo sa aspekta kvaliteta

Neophodno je da Ministarstvo zdravlja Republike Srbije prepozna znaaj ovog

Beograd, 30.10.2013. Institut za epidemiologiju,

Medicinski fakultet Univerzitet u Beogradu

Prof. dr Sandra ipeti-Grujii

Od brojnih afirmativnih utisaka, izdvajaju se dva osnovna.

Prvo, jasno prikazana statistika morbiditeta i mortaliteta od malignih bolesti, prihvatljiva za

Drugo, populacioni registar daje nacionalne koordinate za orijentisanje u oblasti

Beograd, 28.11.2013. godine

Institut za onkologiju i radiologiju Srbije,

Medicinski fakultet Univerzitet u Beogradu

Prof. dr Zorica Miloevi

University of Belgrade Faculty of Medicine

Prof. dr Tatjana Pekmezovic

University of Belgrade Faculty of Medicine

Prof. dr Sandra Sipetic-Grujicic

Institute for Oncology and Radiology of Serbia,

University of Belgrade Faculty of Medicine

Prof. dr Zorica Milosevic

Tabele i slike / Tables and Figures

1. Broj stanovnika prema uzrastu i polu, centralna Srbija, 2012. godina

2. Broj stanovnika prema okruzima i polu, centralna Srbiji, 2012. godina

3. Stanovnitvo prema uzrastu i polu, centralna Srbija, popis 2002. i 2012.

4. Broj novoobolelih osoba od raka prema polu, centralna Srbija, 19902012.

5. Broj umrlih osoba od raka prema polu, centralna Srbija, 19902012.

6. Standardizovana incidencija i mortalitet od raka na 100.000 stanovnika,

7. Standardizovane stope mortaliteta od vodeih lokalizacija raka na 100.000

8. Standardizovane stope mortaliteta od vodeih lokalizacija raka na 100.000

11. Broj novoobolelih sluajeva od raka prema vodeim lokalizacijama,

12. Sirove stope incidencije od raka prema vodeim lokalizacijama, okruzima

14. Broj umrlih sluajeva od raka prema prema vodeim lokalizacijama,

15. Sirove stope mortaliteta od raka prema vodeim lokalizacijama,

16. Standardizovane stope mortaliteta od raka prema vodeim lokalizacijama,

17. Ukupan broj novoobolelih i broj novoobolelih od raka sa procentom

18. Broj novoobolelih sluajeva od raka, prema primarnoj lokalizaciji,

19. Sirove i standardizovane stope incidencije od raka na 100 000 stanovnika,

20. Broj umrlih sluajeva od raka, prema primarnoj lokalizaciji,

21. Sirove i standardizovane stope mortaliteta od raka na 100.000 stanovnika,

22. Ukupan broj novoobolelih, broj i procenat histoloki i citoloki verifikovanih

24. Broj umrlih i mortalitet od raka prema primarnoj lokalizaciji,

Registar za rak u centralnoj Srbiji obuhvata podatke o: linim karakteristikama